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EFFECTS OF EXERCISE, DIETARY PROTEIN, VITAMIN D, 
AND CALCIUM ON PHYSICAL FUNCTIONING AMONG  
MIDDLE-AGED AND OLDER ADULTS 
JABED MUSTAFA 
Boston University School of Medicine, 2016 
Major Professor: Lynn L. Moore, D.Sc., M.P.H., Associate Professor of Medicine 
ABSTRACT 
Exercise and diet may preserve muscle mass and bone health, thereby preventing 
age-related functional decline among older community-dwelling subjects. We 
used data from two studies to examine effects of exercise administered through a 
home-based program for hip fracture patients and the effects of dietary protein, 
vitamin D, and calcium on physical functioning in older adults. In the Health 
and Independence Post-Rehabilitation (HIP) study, the effects of a home-based 
exercise program (vs. attention-based control) (n=232) on functional recovery 
following hip fracture was assessed using two standardized physical 
performance batteries. In a sub-analysis (n=56), we evaluated the effects of food 
frequency questionnaire-derived protein, calcium, and vitamin D intakes on 
these outcomes. In the Framingham Offspring Study (FOS), dietary protein, 
calcium, and vitamin D intakes were measured using two sets of 3-day diet 
records. Physical functioning over 12 years was measured using the Rosow-
viii 
Breslau and Nagi scales. In the HIP study, the exercise intervention led to 
significant improvement in physical performance at 6 months for all primary 
endpoints [(SPPB (P<0.001), AMPAC Mobility Function (P=0.01) and Daily 
Activity (P=0.01). However, we found no beneficial effects of dietary protein, 
calcium, or vitamin D on physical functioning. In the FOS, Cox proportional 
hazard’s models were used to estimate risk of functional decline over 12 years, 
adjusting for potential confounding by age, sex, education, physical activity, 
cigarettes per day, height, and energy intake. Subjects consuming ≥ 1.2 gm/kg 
protein intake (vs. <0.8 gm/kg) had a lower risk of becoming dependent the 
following tasks: heavy work at home; walking one-half mile; climbing stairs; 
stooping, kneeling, crouching; lifting >10 lbs, lifting <10 lbs. Subjects consuming 
≥ 1.2 (vs. <0.8) gm/kg/day of protein had a 41% lower risk of becoming 
dependent in ≥1 functional task over 12 years. The beneficial effect of higher 
protein intake was strengthened among subjects who were more active and had 
higher SMM. There was also evidence of a beneficial interaction of both vitamin 
D and calcium with physical activity and SMM. These results suggest that 
participation in home-based functional exercise in older post-hip fracture adults 
and higher intakes of dietary protein help to preserve functional capacity among 
community-dwelling older adults.  
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CHAPTER ONE: INTRODUCTION 
 
1.1. General introduction 
The population of older adults is growing rapidly in the United States (US) and 
globally. In 1900, 4% of the US population was aged ≥ 65 years compared with 
13% by the end of 20th century. By 2030, it is expected that more than 20% of 
Americans will be 65 years of age or older (1). 
The physiological process of aging is manifested by gradual decline in physical 
and cognitive functioning. This process includes decreases in skeletal muscle 
mass, strength, and bone integrity, which leads to functional decline and 
diminished physical capacity. These physiologic changes can lead to falls, 
fracture, loss of independence, and increased morbidity and mortality (2, 3). 
There are enormous burdens including personal, financial, and productivity 
losses, associated with these trends. Therefore, identification of modifiable risk 
factors for preventing these negative age-related trends and improving quality of 
life among older adults is needed. Two common musculoskeletal disorders 
associated with the development of age-related disability are sarcopenia and 
osteoporosis. These two disorders progress together as they are interrelated 
during the aging process.  
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1.2. Osteoporosis and sarcopenia  
The prevalence of osteoporosis and sarcopenia increases sharply with age. 
Osteoporosis is a skeletal disorder associated with low bone mass and 
deterioration of the bone microarchitecture resulting in bone fragility and 
subsequent increased risk of fracture (4). Factors that affect muscle anabolism 
and catabolism will also affect bone mass. After age 30, loss of skeletal muscle 
occurs at a rate of 3–8% per decade and this loss accelerates with advancing age 
(5). Similarly, bone loss begins in the third or fourth decade of life and annual 
rates of loss increase by > 1% after menopause (6). The lifetime risk of any 
osteoporotic fracture is reported to be 40–50% for women and 13–22% for men 
(7). Osteoporosis and sarcopenia lead to decreased metabolic rate, increased risk 
of falls and fracture, increased morbidity, and loss of independence (8).  
Hip fracture is the most serious fracture related to osteoporosis in both 
developed and developing countries (9, 10). The incidence of hip fracture is 
higher in women than in men and increases exponentially with age (9, 11). 
Consequences of hip fracture can be devastating. One year after hip fracture, 40% 
of patients cannot walk alone, 60% have difficulty with at least one essential 
activity of daily living, 27% have been admitted to a nursing home for the first 
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time, and 20% have died (12). Therefore, prevention or delay in the occurrence of 
osteoporosis and sarcopenia is essential to the maintenance of independence and 
quality of life.  
1.3. Role of dietary protein in bone health 
Skeletal muscle contains 50–75% of all proteins in the human body (13). Protein 
plays an essential role in both bone metabolism and muscle anabolism. 
Inadequate protein can lead to sarcopenia and osteoporosis. Protein promotes 
the synthesis of type I collagen in the formation of the bone matrix through post-
translational modifications of amino acids, which include hydroxylation of lysine 
and proline, and other non-collagen proteins in the bone matrix (14). Protein is 
also involved in the production and action of insulin-like growth factor-1 (IGF-1), 
the most abundant growth factor in the bone matrix. The anabolic function of 
amino acids on bone is mediated through the stimulation of IGF-I (15), which 
increases bone mass by osteoblast activity as well as mineralization of the bone 
matrix (16). In a study of humans with caloric restriction and reduced protein 
intake (from 1.67 to 0.95 g/kg of body weight per day) for 3 weeks, serum IGF-1 
was reduced from 194 ng/ml to 152 ng/ml. Also, it was found in undernourished 
elderly individuals with hip fracture that protein supplementation of 20 g/d 
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could increase IGF-1 production and attenuate proximal femur loss (17). 
Therefore, inadequate intake of dietary protein may cause changes in the bone 
microstructure and lead to decreased bone strength (18).  
Epidemiologic studies suggest that protein quantity is positively associated with 
bone metabolism and BMD (Bone Mineral Density) (19–21). The Framingham 
Osteoporosis study showed that elderly men and women with the highest 
protein intakes (84–152 g/day) had the greatest protection against bone loss in the 
spine and femoral regions compared with those who consumed less protein (17–
51 g/day) (22). In the third National Health and Nutrition Examination Survey 
(NHANES), postmenopausal women with dietary protein intakes above 75 g/day 
had a higher total BMD in the hip (19). In an Iowa prospective study of 40,000 
women, higher protein intakes reduced the risk of hip fracture by 69% (20) and a 
case-control study of 2,500 men and women found that those in the highest 
quartile of protein intake (17.4–30.8% of energy), had a 65% lower incidence of 
hip fracture (21). 
There is controversy about the effect of protein on calcium absorption. While 
some studies have suggested that high protein intake leads to decreases in 
reabsorption of calcium and a resulting increase excretion of calcium (23, 24). In 
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contrast, other studies have shown that low protein intakes decrease calcium 
absorption, leading to secondary hyperparathyroidism, thereby promoting bone 
loss and reduced bone density (23). One study found that increasing dietary 
protein from 10% to 20% of calories leads to increased intestinal absorption of 
calcium with no negative effect on skeletal calcium balance (25). It is possible that 
low calcium intake may lead to greater calcium resorption from bone and higher 
urinary calcium. In the Nurse’s Health Study with 12 years of follow up, protein 
intakes above 90 g/d were associated with a greater risk of forearm fracture (OR 
= 1.22, 95% CI 1.04 to 1.43) in a cohort of 85,900 women aged 35–59 years. 
However, a 31% higher risk of fracture (RR=1.31; 95% CI 0.94–1.82) was found 
among women with high protein but low calcium (≤541 mg/day) diets, which 
suggests that risk of forearm fracture may be primarily linked with lower 
calcium intakes (26). In another epidemiologic study of 2,408 women with hip 
fracture, women with high protein intake who were in the lowest quartile of 
calcium intake (<400 mg/1,000 kcal) had significantly greater risks of fracture 
(RR: 1.51, 95% CI 1.17– 1.94) for highest versus lowest quartile (27). Similarly, 
another study observed that subjects with high protein intakes (20.6 g/d, highest 
quartile) but low calcium intakes (435 mg/d, lowest quartile) had almost double 
the risk of hip fracture (RR 1.96, 95% CI 1.09–3.56) (28). Finally, a clinical trial of 
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postmenopausal women found that a high-meat diet (117 g of protein per day or 
1.62 g/kg/d) had no effect on calcium excretion or any biochemical marker of 
bone turnover compared with those with low meat diet (45 g/d of meat and 68 
g/d of protein) (29).  
1.4. Effect of dietary protein intake on muscle mass and physical functioning 
Anabolic stimuli for muscle protein synthesis are activated by the mammalian 
target of rapamycin (mTOR) signaling cascade. In human muscle protein 
synthesis, feeding is associated with enhanced phosphorylation and activation of 
the mTOR signaling pathway, which includes 70-kDa ribosomal protein S6 
kinase (S6K1) and its target ribosomal protein S6 (rpS6). Protein synthesis is 
tightly regulated by the activation of guanine nucleotide exchange factor 
eukaryotic initiation factor 2B (elF2B), which is responsive to amino acid intake 
and controlled by glycogen synthase kinase-3b (30).  
Physiologically, protein plays an anabolic role. The amino acid leucine and IGF-1 
act as stimuli for muscle metabolism. In older subjects, studies have found that 
an increase in amino acid availability causes an increase in protein synthesis (31). 
One report on health, aging, and body composition in a population of 2000 
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subjects, ages 70–79 years showed the importance of protein intake in preserving 
lean body mass. Those in the highest quintile of protein intake had less age-
related loss of lean mass over 3 years compared with those with the lowest 
quintile of protein intake (32). Reduced muscle mass could also lead to 
impairment of physical functioning and increased risk of disability and falls (33). 
A similar study reported that low protein intake (0.5 g/kg/day vs. 1.2 g/kg/d) 
resulted in muscle wasting in older adults (34). Thus, a number of investigators 
have argued that increasing daily protein intake (beyond 0.8 g/kg/d) enhances 
muscle protein anabolism and helps to reduce the progressive age-related loss of 
muscle in healthy adults with normal renal function (35). 
1.5. Dietary Guidelines: protein requirements 
The minimum protein intake necessary to prevent muscle wasting has been 
determined by nitrogen (N) balance studies. Nitrogen balance exists when intake 
equals losses (through the skin via sweat, urine, and feces).  According to Food 
and Nutrition Board recommendations, the estimated average requirement 
(EAR) for protein intake under normal conditions is 0.66 g/kg per day and the 
recommended dietary allowance (RDA) is 0.8 g/kg per day. For optimal protein 
utilization, it is estimated that about 10–35% of total energy should come from 
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protein (36). This very wide range, however, reflects the considerable 
controversy surrounding what constitutes adequate protein intakes throughout 
the lifespan. A number of studies suggest that positive nitrogen balance is 
frequently overestimated (37). In addition, older individuals may require more 
protein due to a hyper catabolic state compared with younger persons (38). At 
the current time, the optimal level of protein intake is not clear.  
1.6. Role of vitamin D and calcium on muscle and bone health 
Circulating calcium ions regulate a number of processes including muscle 
contraction and relaxation indicating that normal serum calcium is vital for 
muscle function and physical performance. Likewise vitamin D receptors are 
present in all tissues including skeletal muscle; therefore, vitamin D is also 
implicated in muscle contraction, strength, and physical performance (39, 40). In 
recent decades, studies have shown that vitamin D status (25(OH)D) is 
associated with calcium homeostasis, musculoskeletal health, cardiovascular 
health, diabetes mellitus, hypertension, and osteoarthritis (41). Therefore low 
vitamin D status in middle-age and older adults may lead to poorer physical 
functioning through its effects on muscle, bone, and associated comorbidities 
(42). Low vitamin D status in older adults is common due to reduced outdoor 
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activities (less exposure to ultraviolet B), reduced efficiency of vitamin D 
synthesis in the skin, and inadequate intake (43, 44). Older adults are the most 
vulnerable group for vitamin D deficiency due to reduced capacity for vitamin D 
synthesis in the skin, limited exposure to the sun, lower food intakes, reduced 
intestinal absorption, and less renal production of cholecalciferol (45–48). In 
particular, there is a decrease in cutaneous levels of 7-dehydrocholesterol with 
aging thus reducing the capacity to produce vitamin D3 in skin (45). Data from 
the 2000–2004 NHANES indicates that about one-third of adults ages 70 and 
higher are vitamin D deficient (25(OH)D <20 ng/mL) and 75% were vitamin D 
insufficient (25(OH)D <30 ng/mL) (49). One study found that 80–100% of elderly 
home care residents living in Europe, Australia and North America were vitamin 
D deficient (50).  
The biological activity of vitamin D is mediated by 1,25(OH)D. It acts on high-
affinity receptor VDR, which is distributed throughout the body including bone 
and muscle cells (51). This membrane-bound VDR mediates the action of 
1,25(OH)D on calcium influx and muscle contractility (52). The 1,25(OH)D acts 
on the VDR, which activates gene transcription resulting in the synthesis of 
specific proteins and regulation of bone and muscle cell differentiation and 
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proliferation (53).   
Vitamin D helps to maintain calcium and phosphorus homeostasis and bone 
health by acting on tissues in the intestines, kidneys, and bone (54). It absorbs 
calcium and phosphorus from the intestine, thereby promoting bone 
mineralization and making bones stronger through adequate calcium and 
phosphorus availability. Inadequate intake and sun exposure can lead to vitamin 
D deficiency resulting in decreased absorption of calcium and phosphorus from 
the intestine. Decreased plasma calcium can lead to hyperthyroidism as a 
physiologic response and as a result, may promote resorption of calcium from 
bone leading to osteoporosis (43, 55). 
1.7. Vitamin D and calcium affect muscle health and physical functioning  
The major extra-skeletal effects of vitamin D relate to muscle health, including 
muscle strength and improved physical performance. Myopathy, which is 
characterized by muscle weakness and wasting, is associated with vitamin D 
deficiency (56, 57). Several observational and clinical studies found an 
association between vitamin D and calcium with physical functioning outcomes. 
A number of cross-sectional studies have found a link between vitamin D status 
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<75 nmol/l and poor functional outcomes (58–62). Several prospective studies 
also revealed positive associations between vitamin D and physical functioning. 
In the Longitudinal Aging Study of Amsterdam (LASA) with 3 years of follow 
up, older adults with 25(OH)D <50 nmol/l had decreased physical functioning 
compared with subjects with higher a 25(OH)D ≥75 nmol/l (63). In the Rancho 
Bernardo prospective study with 2–5 years of follow up, women (but not men) 
with 25(OH)D levels ≥115 nmol/l performed better on lower extremity physical 
performance tests than women whose 25(OH)D levels were ≤80 nmol/l (64). A 
study among older Italians found positive association between vitamin D status 
and frailty status in older men but not older women (60). Finally, a 3-month 
prospective study among Japanese older women with physical impairments 
found that higher baseline 25(OH)D levels (>67.5 nmol) were linked with better 
physical functioning associated with an exercise intervention compared with 
subjects with lower 25(OH)D levels (65). 
Some clinical trials studies have also revealed a positive association between 
vitamin D and physical functioning. In a clinical trial among 242 community 
dwelling subjects (mean aged 77 years), subjects with 1000 mg of calcium plus 
800 IU of vitamin D (vs. 1000 mg of calcium alone) had improved significantly in 
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reducing falls and improved muscle function (quadriceps strength, body sway, 
time needed to perform the TUG test) over 12 months of follow-up (66). 
However, not all studies identified a positive association between vitamin D and 
calcium intakes and physical functioning outcomes. The Women’s Health 
Initiative (WHI) double-blind, placebo-controlled clinical trial study, for instance, 
33,067 women aged 50 to 79 years at 40 US study centers with 1,000 mg calcium 
carbonate plus 400 IU vitamin D3 supplementation, after followed for 7.1 years 
did not improve the declining physical functioning in older women compared to 
the placebo (67). 
1.8. Summary  
The onset of disablement starts with age-related physiologic changes occurring 
in the musculoskeletal system that may lead to sarcopenia and osteoporosis. 
These changes may in turn lead to deterioration of physical functioning in 
middle-aged and older adults. This dissertation proposes to provide additional 
data to the on-going examination of whether age-related physical decline can be 
delayed by consuming more dietary protein, vitamin D, or calcium. The question 
will be explored in two very different ways. First, the short-term effects of 
dietary protein, vitamin D, and calcium on recovery of physical functioning in a 
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unique population of elderly post-hip fracture subjects will be examined. 
Secondly, the long-term effects of dietary protein, vitamin D, and calcium on 
changes in physical functioning in middle-aged and older subjects will be 
estimated in the Framingham Offspring Study. In addition, we will explore the 
modification of these dietary effects by physical activity, BMI, and skeletal 
muscle mass. 
The following objectives will be explored in the next four chapters of this 
dissertation. 
 
1. Study 1: To compare effects of functionally-oriented, home-based exercise 
program (vs. non-exercise control) on change in functional performance 
and activities of daily living following the completion of a formal hip 
fracture rehabilitation program 
2. Study 2: Sub-study (pilot): To explore effects of dietary protein, calcium, 
and vitamin D on measures of physical functioning among post-hip 
fracture subjects 
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3. Study 3: To estimate effects of dietary protein on physical functioning 
among middle-aged and older adults (≥ 50 years) in the Framingham 
Offspring (FOS) 
4. Study 4: To estimate effects of calcium and vitamin D on physical 
functioning over time among middle-aged and older adults  (≥ 50 years) 
among Framingham Offspring Study (FOS). 
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CHAPTER TWO: HOME-BASED EXERCISE, PROTEIN, VITAMIN D, AND 
CALCIUM AND FUNCTIONAL OUTCOMES AMONG OLDER ADULTS 
FOLLOWING HIP FRACTURE 
 
2.1. STATEMENT BY THE AUTHOR 
The Health and Independence Post-Rehabilitation (HIP) Study was conducted 
among 232 post-hip fracture subjects to assess whether a 6-month functionally 
oriented, home exercise program would improve functional performance after 
the conclusion of formal hip fracture rehabilitation. The study was a randomized 
clinical trial with a control group that received nutritional counseling for 
cardiovascular disease (CVD) prevention. Subjects were followed for nine 
months from enrollment to determine whether functional gains from the exercise 
program occurred and persisted. 
I was the primary research staff member who collected all of the home-based 
information. I was directly involved in essentially almost all aspects of the study. 
I assessed subjects’ eligibility, performed informed consent procedure, 
administered baseline and follow-up data collection (demographics, functional 
performance, mental status, etc.). I entered all outcome data into an Access data 
base. Finally, I carried out a sub-study also reported in this chapter in which I 
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administered a Food Frequency Questionnaire (FFQ) to 56 subjects at baseline 
and follow up to obtain nutrient data on dietary protein, vitamin D, and calcium 
intake.  
The Principal Investigator for the main clinical trial was Dr. Nancy Latham; she 
is the first author of the paper reporting the main results. I am a co-author on 
that manuscript which is included in the appendix (published in JAMA 
2014;311:700–708) (See Appendix).  
2.2. Background 
Populations are aging rapidly in the US and globally. With increasing age, 
physical functioning begins to decline leading to higher levels of disability (68).  
As life expectancy increases, the disease burden and financial costs associated 
with functional disability and resulting medical care are also rising (69).  It has 
become a major public health challenge to keep the aging population as healthy 
and functionally independent as possible (70, 71). 
Osteoporosis is a worldwide public health problem affecting both men and 
women of all races. According to the National Osteoporosis Foundation, there 
are over 10 million people over 50 years of age with osteoporosis and another 34 
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million are at risk of developing osteoporosis (72). Osteoporosis and low bone 
mass are the major risk factors for serious bone fractures including hip fracture 
(73). Ninety-five percent of hip fractures occur as a result of falling (74). More 
than 281,000 older adults in the US suffer from hip fracture each year (75).  
Hip fracture often leads to functional impairment, nursing home admission and 
increased mortality (76, 77). One study showed that about 25% of adults who led 
independent lives prior to hip fracture required nursing home care for more than 
one year after the fracture injury (75). More than 20% of those sustaining such a 
fracture die within one year (75). Women are more at risk of hip fracture than 
men, with 75% of all hip fractures occurring in women (78). Hip fracture rates for 
both men and women rise exponentially with age (79). Compared to people aged 
60 to 65, those who are 85 years and older are at 10 to 15 times the risk of hip 
fracture (80). Each year about 250,000 hospital admissions for hip fractures 
occurred among people aged 65 and older each year (81) and was among the 10 
most costly chronic conditions to Medicare (82). Annually the number of 
osteoporotic fractures outnumbers the total incidence of heart attack, stroke, and 
breast cancer combined (83–85). Thus, there are enormous economic burdens 
associated with osteoporotic fractures. By 2025, the annual cost is expected to rise 
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to $25.3 billion (83).   
Recovering long-term functional independence is a major challenge for those 
who sustain a hip fracture. Towards this end, traditional hip fracture 
rehabilitation incorporates intensive physical therapy follow-up either on an in-
patient basis or under direct supervision of a therapist at home. There are few 
data available on the efficacy of home-based self-directed exercise programs in 
maintaining and extending the benefits of acute rehabilitation. Success of such 
programs would have important financial as well as functional implications for 
hip fracture patients. There is also the need to identify other modifiable risk 
factors that are associated with functional status and musculoskeletal health in 
this particular population. Prior studies suggest that vitamin D, calcium, and 
protein may improve musculoskeletal health (14, 86–91). There is a lack of 
studies examining the effects of vitamin D, calcium, and protein intake on 
objective measures of physical performance in elderly subjects following hip 
fracture.  
The Health and Independence Post-Rehabilitation (HIP) Study was designed to 
test the effectiveness of a functionally oriented, home-based exercise program on 
change in functional performance after formal hip fracture rehabilitation, 
19 
 
compared with a control group that received only nutritional counseling for 
cardiovascular health during the post-rehabilitation period. A sub-study that 
serves as a pilot study is also reported on in this chapter. The goal of this pilot 
study was to examine the effects of usual intakes of protein, calcium, and vitamin 
D on the same measures of physical functioning as were collected in the study.  
2.3. Study design 
The original HIP Study was conducted by the Health and Disability Research 
Institute (HDRI) of Boston University School of Public Health and Harvard 
Medical School as a parallel group design randomized controlled clinical trial 
with blinded outcome assessment. The study was approved by each site’s 
institutional review board. Data were collected between September 2008 and 
October 2012. A total of 232 subjects living in the greater Boston, MA area were 
randomized in the original study. Subjects were identified through 
advertisements and recruited from acute care and rehabilitation hospitals, skilled 
nursing facilities, and home care agencies. After completion of their 
rehabilitation for hip fracture, informed consent was obtained to enroll in the 
HIP study. Approval from subjects’ primary care physicians and, if required, 
orthopedic surgeon was obtained. 
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The eligibility criteria for the study included the following: age 60 years and 
above, primary diagnosis of hip fracture, discharge from rehabilitation services 
within 20 months of the baseline assessment, ability to safely complete sit to 
stand with or without a mobility device, and some functional limitation (at least 
one limitation in the S-36 physical function scale). The exclusion criteria for the 
study were severe cognitive deficiency [less than 20 in Mini Mental State Exam 
(MMSE)], severe depression [10 or greater in Geriatric Depression Scale (GDS)], 
survival expectancy less than 1 year (terminal illness), other pre-existing 
conditions precluding participation in the exercise program including 
pulmonary or cardiovascular contraindications, legal blindness, residence 
outside the catchment area, bilateral hip fractures, hip fracture due to 
malignancy, and rapidly progressive neurological disorders.  
Participants were allocated to the HIP exercise intervention or attention control 
(i.e. nutrition education) groups using a computerized central randomization 
scheme generated by the study’s biostatistician. A stratified block randomization 
technique was used to ensure that the number of patients in the treatment arms 
was balanced by sex, functional level and most recent type of rehabilitation.  
Block size randomly varied between 6 and 8 to minimize the possibility of 
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breaking the randomization scheme.  After enrolling participants, obtaining 
consent and completing all baseline assessments, randomization was done. 
The intervention group was instructed to perform the HIP exercise program 
three times per week for six months. Details of the specific interventions are 
shown in Table 2.1 below. 
This program was taught in three home visits conducted by a physical therapist 
(PT). The PT also provided monthly phone calls. All subjects were provided with 
a DVD version of the program. I completed all physical performance 
measurements at baseline and at the primary endpoint, 6 months after 
randomization, as well as a follow-up assessment at 9 months (n=212).  
For the sub-study examining the association between the intake of protein, 
calcium, and vitamin D and physical performance outcomes, I administered the 
Harvard FFQ at baseline and follow up to 56 subjects in the intervention or 
control groups between June, 2010 and November, 2011. 
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Table 2.1 Components and methods of Hip Rehab Program  
Exercises 
Warm up DVD, exercise manual 
Hip extension Theraband, DVD, exercise manual 
Heel raises onto toes Theraband, DVD, exercise manual 
Resisted rowing  Theraband, DVD, exercise manual 
Standing diagonal reach Theraband, DVD, exercise manual 
Modified get up and go Theraband, DVD, exercise manual 
Overhead arm extensions Theraband, DVD, exercise manual 
Repeated chair stands Vest, DVD, exercise manual 
Lunges – forward and back Vest, DVD, exercise manual 
Stepping up and down step 
Vest, plyometric step, DVD, exercise 
manual 
Calf raises – both legs and one leg Vest, DVD, exercise manual 
Cool down DVD, exercise manual 
Cognitive and behavioral strategies 
Individualized goal setting Exercise calendar 
Discussion about exercise Exercise: It’s Never Too Late video 
Discussion of fear of falling A matter of balance video 
Self-Monitoring of progress Borg rating of perceived exertion chart 
PT Role 
Initial assessment Initial in-person home visit 
Modification of exercises In person visits 2–3; follow-up phone calls 
Cognitive-behavioral strategies In person visits 2–3; follow-up phone calls 
Program modification  In person visit 4 
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Physical functioning outcomes 
Functional outcomes were assessed using several well-validated and 
standardized physical functioning measurement tests. These tests were 
administered by a single blinded evaluator in the subjects’ homes at baseline, 6 
months after randomization, and at a 9 month follow-up visit. The physical 
functioning measurement tests included the Activity Measure for Post-Acute 
Care (AM-PAC), the Short Physical Performance Battery (SPPB), a Leg muscle 
Strength Test (for both the fractured and non-fractured leg), the Berg Balance 
Test, and a test of reaction time. 
Activity Measure for Post-Acute Care (AM-PAC). The AM-PAC evaluates self-
reported physical functioning. It assesses two domains: Basic Mobility and Daily 
Activity. The Basic Mobility domain has 32 items and the Daily Activity domain 
has 26 items. The score ranges for Basic Mobility from 23 to 85 and for Daily 
Activity from 9 to 101 (with higher scores indicating better physical functioning) 
(92, 93).  
Short Physical Performance Battery (SPPB). The SPPB primarily assesses lower 
extremity performance. This measure consists of three components: standing 
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balance, gait speed, and chair stand. Standing balance includes a side-by-side 
stand, semi-tandem stand, and tandem stand. Gait speed includes walking 4 
meters at the subjects’ usual pace. Chair stand consists of standing up from chair 
and sitting down 5 times. The score range is 0 to 12, with higher score indicating 
better physical functioning (94). 
Leg Muscle Strength. Subjects’ isometric quadriceps strength was measured with 
a strain gauge dynamometer developed by Lord et al and validated for use with 
hip fracture patients. The test followed the protocol of Lord et al and measured 
bilateral knee extension force in pounds on the fractured and non-fractured legs 
(95).  
Berg Balance Test. Subjects’ balance was assessed using the Berg Balance Test, a 
well validated performance-based measure of balance in older people. Test 
performance is rated from 0 to 4 on 14 functional tasks that include static and 
dynamic balance activities. Total scores range from 0 (severe balance 
impairment) to 56 (normal balance) (96–98). 
Reaction Time. A reaction time test was administered following a protocol 
developed by Lord et al (95, 99, 100). Reaction time was measured as the time it 
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took for the participants to click a mouse when a light flashed. Subjects were 
asked to perform the task 15 times. The first five were counted as practice tests, 
and the following 10 reaction times were counted as the actual reaction time 
performance. The mean of the 10 reaction time scores was considered the 
subject’s reaction time in milliseconds. A lower reaction time indicates better 
reaction time. 
 Dietary protein, vitamin D and calcium intake assessment   
The FFQ was administered to a subset of the original HIP study subjects at 
baseline. I asked each subject to complete the questionnaire with respect to usual 
dietary intake over the past year. Nutrient data for daily intake of vitamin D, 
calcium (from food sources and supplements), and protein intake were derived 
from the completed FFQ forms by the Harvard School of Public Health Nutrition 
Department. 
Potential confounding variables  
Demographic variables. Demographic information for all subjects included age, 
sex, race (self-assigned), and education level was collected at baseline. 
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Comorbidities. Study subjects self-reported comorbidities were assessed using 
Katz Co-Morbidity Index (101). Subjects were asked to report if they had ever 
been diagnosed by a doctor with one or more common comorbidities including 
heart disease, diabetes, cancer, osteoarthritis, depression, and lung diseases. 
Subjects’ comorbidity status was converted to a composite score for further 
statistical analysis with 0, 1, and ≥2 reflecting no comorbidity, a single 
comorbidity, and two or more comorbidities, respectively. 
Physical Activity. Subjects’ self-reported physical activity over the past year was 
measured at baseline using the Stanford Brief Activity Survey (102).  
Mini-Mental State Examination (MMSE). Subjects’ cognitive status was measured 
using the MMSE (103), with scores ranging from 0 to 30, with a higher score 
indicating better cognition.  
Geriatric Depression Scale (GDS). In addition to cognitive status, subjects’ self-
reported depression status was measured by the Geriatric Depression Scale Short 
Form (104). Scores ranged from 0 to 15, with a higher score indicating worse 
depression. 
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Statistical methods 
As a check on randomization, baseline characteristics of the Exercise and Control 
groups were compared through the independent sample t-test (for continuous 
measures) and the chi-square test (for categorical characteristics).  Baseline 
characteristics were compared for those followed versus those lost to follow up 
at 6 months.  The primary analyses for this trial were conducted on an intention-
to-treat basis, in that subjects were analyzed according to their randomized 
assignment, regardless of whether or not they complied with the study protocol 
or completed the study.  Mixed effects linear regression models for longitudinal, 
repeated-measures data were used to examine changes in outcomes from 
baseline to 6 and 9 months. These models included interaction terms between 
study group (Exercise vs. Control) and time (0, 6, or 9 months) to model 
differential changes from baseline to 6 months, and baseline to 9 months, for 
those in the Exercise vs. Control groups. In addition to the unadjusted models, 
we also controlled for a-priori identified potential confounding variables and 
other variables expected to be strongly associated with outcomes. SAS version 
9.3 was used for all analyses. 
Statistical analysis for the sub-study (n=56) used subjects’ mean nutrient intakes 
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of dietary protein, vitamin D, and calcium per day derived from the Harvard 
FFQ. Given the small sample size and to optimize power, I classified subjects into 
tertile of intake. Subjects’ baseline characteristics by tertile group of dietary 
protein, vitamin D, and calcium intakes were then compared to identify any 
potentially important differences among groups using the independent sample t-
test for continuous characteristics and chi-square test for categorical 
characteristics. I first used linear regression modeling to examine the association 
between subjects’ dietary protein, vitamin D, and calcium intakes (on a 
continuous scale) with physical functioning outcomes from the AM-PAC, SPPB, 
Leg muscle strength, Berg balance test, and reaction time. I then used analysis of 
covariance (ANCOVA) models to compare the mean performance on each of the 
functional outcomes according to tertiles of intake for each of the three nutrients. 
As a pilot study, the focus of this sub-study was not statistical testing. 
2.4. Results of the main study 
We identified 1546 potentially eligible people (see Flow Chart in Figure 2.1), with 
1314 people not randomized because they did not meet the criteria, did not 
receive primary care physician clearance, refused, or were unable to be 
contacted. A total of 232 people were randomized, 112 to the control group and 
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120 to the exercise intervention group. A total of 37 people were lost to follow up 
at 6 months (the primary end point), which was 15.9% of the randomized 
sample. There were no significant differences in the characteristics of the people 
who were lost to follow-up based on age, baseline function, sex or any other 
characteristic.  
As shown in Table 2.2 below, there were no significant between-group 
differences at baseline. The mean age of the participants at enrollment was 78.0 
(SD 9.9) and 69% of the participants were female. The mean (SD) SPPB score was 
5.9 (2.8) at enrollment, which was consistent with the presence of severe 
functional limitations (105, 106).  
The exercise group showed significant improvement from baseline to 6 months 
relative to the control group in almost all the functional measures (Table 2.3). The 
mixed-models analyses found improved self-reported basic and daily activity 
function and improved physical performance mobility scores. The effects 
remained significant even after adjusting the analyses for age, gender, time since 
fracture and baseline functional scores (SPPB P<0.001; AM-PAC Mobility 
Function P=0.01; AM-PAC Daily Activity Function P=0.01).  
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232 Randomized 
Intervention 
group 
Control group 
Figure 2.1. Patient recruitment, attrition, and retention flow chart  
 
 
 
 
 
                              
                                                                                             
 
 
 
 
1546 Functionally limited older adults with a hip fracture were assessed for eligibility 
1314 Excluded:  
384 Did not meet inclusion criteria 
       85 Fracture > 2 y ago 
       69 Diagnosed not hip fracture 
       68 Not considered medically stable 
       46 Had dementia 
       22 Lived outside geographic area 
       94 Other  
378 Refused to participate 
  78 Died 
474 Unable to contact  
120 Randomized to receive a hip 
rehabilitation program  
112 Randomized to receive 
cardiovascular nutrition education  
95 Included in primary analysis at 6 mo  
17 Excluded  
  2 Too ill for assessment 
10 Refused/ unable to schedule visit 
  4 Unable to contact 
  1 Died 
100 Included in primary analysis at 6 mo  
  20 Excluded 
 9 Too ill for assessment 
 7 Refused/unable to schedule visit 
 3 Unable to contact 
 1 Moved out of state 
74 Included in analysis at 9-mo follow-up 
26 Excluded 
  9 Too ill for assessment visit 
10 Refused/unable to schedule   visit 
  3 Unable to contact 
  2 Moved out of state 
  2 Died  
68 Included in analysis at 9-mo follow-up 
27 Excluded 
  7 Too ill for assessment visit 
11 Refused/unable to schedule visit 
  6 Unable to contact 
  1 Moved out of state 
  2 Died 
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Table 2.2 Baseline demographic and clinical characteristics of control and 
intervention subjects 
Variable Control Intervention P Value 
 (n=112) (n=120)  
Age, mean (SD), y 78.9 (9.4) 77.2 (10.2) 0.17 
Female sex, N (%) 77 (68.8) 83 (69.2) 0.95 
White race, N (%) 97 (86.6) 109 (90.8) 0.31 
Bachelor's degree or higher, N (%) 48 (42.8) 41 (42.5) 0.17 
Currently living alone 48 (42.8) 41 (42.5) 0.17 
Most recent therapy site, N (%)    
    Outpatient 42 (42.9) 57 (47.5)  
    Inpatient 2 (1.80) 1 (0.8) 0.42 
    Home 62 (55.4) 62 (51.7)  
Time since fracture, mean (SD), mo 8.6 (4.8) 9.5 (5.2) 0.20 
Mini-Mental State Exam score, mean (SD)1 28.7 (2.0) 28.8 (1.7) 0.50 
Geriatric Depression Scale score, mean (SD)2 2.4 (1.9) 2.6 (2.0) 0.49 
Type of comorbidity, N (%)    
    Heart disease 38 (34.2) 42 (35.6) 0.83 
    Diabetes 16 (14.4) 14 (11.9) 0.57 
    Cancer 33 (29.7) 36 (30.5) 0.90 
    Osteoarthritis 71 (64.0) 64 (54.2) 0.14 
    Depression 17 (15.3) 22 (18.6) 0.50 
    Lung disease 18 (16.2) 15 (12.7) 0.45 
SPPB score, mean (SD)3 5.9 (2.8) 5.9 (2.8) 0.96 
AM-PAC score, mean (SD)    
     Mobility4 55.7 (7.1) 56.1 (7.3) 0.71 
     Daily Activity5 58.0 (15.0) 57.2 (13.8) 0.66 
Berg Balance Test score, mean (SD)6 40.2 (10.8) 40.8 (11.8) 0.68 
Leg strength score, mean (SD), lb    
     Fractured leg 25.6 (13.3) 25.5 (11.4) 0.95 
     Nonfractured leg 29.0 (12.1) 29.0 (12.1) 0.76 
AM-PAC, Activity Measure for Post-Acute Care; SPPB, Short Physical Performance Battery 
The mean changes in the SPPB score at 6 months for the exercise and control 
group were +1.0 (Confidence Interval (CI 0.8, 1.3) and +0.2 (CI 0, 0.5) respectively. 
For the AM-PAC Mobility Function, the changes for the exercise and control 
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group were +1.9 (CI 1.1, 2.7) and +0.6 (CI -0.2, 1.4), respectively, while for the 
AM-PAC Daily Activity scale, the changes for exercise and control groups were 
+3.9 (CI 2.2, 5.7) and +0.5 (CI -1.3 to 2.2). These differences exceed the minimal 
important clinical difference (MCID) for both the SPPB and the AM-PAC daily 
activity function. The MCID is 0.3–0.8 points for the SPPB (106) and 3.9 points for 
AM-PAC Daily Activity (93).  
The differences in function between the two groups persisted at the 9-month 
follow-up assessment. Both adjusted and unadjusted analyses continued to find 
significant difference between the two groups. The differences in the change 
scores between the two groups increased for two of the measures: for the SPPB 
there was a 1.0 difference at 9 months compared to a 0.8 difference at 6 months, 
while for the AM-PAC mobility there was a 1.7 point difference at 9 months 
compared to a 1.3 point difference at 6 months. The between group differences in 
the change scores for AM-PAC Daily Activities did decline slightly at 9 months, 
from 3.5 points at 6 months to 2.8 points at 9 months. 
Balance significantly improved in the exercise compared to the control group at 6 
months (p<0.001).  Muscle strength significantly improved in the non-fractured 
(p=.02), but not in the fractured leg (p=0.16).  Both groups had a high number of 
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health events that were unrelated to the study, which is consistent with the high 
level of comorbidity in this population. 
Table 2.3. Between group differences in functional outcomes  
 
 Mean (SD) Change from baseline (95%CI) 
  Baseline 6 mo 9 mo 6 mo 9 mo 
SPPB2           
Exercise group3 5.9 (2.8) 7.2 (3.0) 7.6 (2.9) 1.0 (0.8, 1.3) 1.3 (1.0, 1.5) 
Control group4 5.9 (2.8) 6.2 (3.0) 6.3 (2.9) 0.2 (0, 0.5) 0.3 (0, 0.6) 
Exercise vs. control       0.8 (0.4, 1.2) 1.0 (0.6, 1.4) 
AM-PAC mobility5         p <0.001  
Exercise group3 56.1 (7.3) 58.1 (7.9) 59.5 (9.3) 1.9 (1.1, 2.7) 2.6 (1.9, 3.4) 
Control group4 55.7 (7.1) 56.6 (8.1) 56.7 (7.6) 0.6 (-0.2, 1.4) 1.0 (0.2, 1.8) 
Exercise vs. control       1.3 (0.2, 2.4) 1.7 (0.5, 2.8) 
AM-PAC daily 
activity6         p=0.01  
Exercise group3 57.2 (13.8) 61.3 (15.7) 63.0 (15.9) 3.9 (2.2, 5.7) 4.2 (2.5, 6.0) 
Control group4 58.0 (15.0) 58.6 (15.3) 59.0 (14.9) 0.5 (-1.3, 2.2) 1.4 (-0.4, 3.3) 
Exercise vs. control       3.5 (0.9, 6.0) 2.8 (0.3, 5.4) 
Berg balance test7         p=0.01  
Exercise group3 40.8 (11.8) 44.4 (10.7) 45.6 (10.0) 2.4 (1.6, 3.2) 2.7 (1.9, 3.6) 
Control group4 40.2 (10.8) 41.1 (10.7) 40.4 (11.4) 0.1 (-0.7, 1.0) 0.1 (-0.8, 1.0) 
Exercise vs. control       2.3 (1.1, 3.5) 2.7 (1.4, 3.9) 
Strength-fx’d leg, lb         P<0.001  
Exercise group3 25.5 (11.4) 27.7 (12.8) 29.9 (12.9) 1.9 (0.3, 3.5) 2.3 (0.6, 4.0) 
Control group4 25.6 (13.3) 26.7 (14.3) 25.6 (14.2) 0.3 (-1.5, 2.2) 0 (-1.9, 3.5) 
Exercise vs. control       1.5 (-0.9, 4.0) 2.3 (-0.3, 4.8) 
Strength-nonfx, lb          p=0.16 
Exercise group3 29.0 (12.1) 29.4 (13.3) 30.8 (13.7) 0 (-1.6, 1.7) 0.4 (-1.3, 2.1) 
Control group4 29.0 (12.1) 28.8 (13.9) 25.8 (13.6)  -0.8 (-2.5, 0.8)  -3.1 (-4.8, -1.3) 
Exercise vs. control       0.9 (-1.5, 3.2) 3.5 (1.0, 5.9) 
           p=0.02 
AM-PAC, Activity Measure for Post-Acute Care; SPPB, Short Physical Performance Battery; fx, fracture 
1. Compares trend over time, controlling for age and sex. 
2. The score range is 0 to 12, with a higher score indicating better function. 
3. There were 120 participants at baseline, 100 at 6 months, and 94 at 9 months. 
4. There were 112 participants at baseline, 95 at 6 months, and 85 at 9 months.  
5. The score range is 23 to 85, with a higher score indicating better function. 
6. The score range is 9 to 101, with a higher score indicating better function. 
7. The score range is 0 to 56, with a higher score indicating better balance. 
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2.5 Result of pilot study 
Table 2.4 below shows the baseline characteristics of study subjects (n = 56) 
according to calcium intake. Average intake of calcium was 1480.7 mg. Mean age 
of the study subjects was 77.9 years. The middle tertile group was the oldest (82.1 
years) compared with the two other tertiles. Among the subjects, females were 
higher in number (n = 33) compared to males (n = 23).  Nearly all subjects (n = 54) 
were white with only 2 being non-white. There were no statistically significant 
differences of baseline characteristics except the age by calcium intake tertile 
group.  
Table 2.5 shows the baseline clinical characteristics and energy intake from the 
macronutrients according to calcium intake. There were no significant 
differences across the tertile groups in any of the clinical characteristics and 
macronutrients intake at baseline except in total calorie intake. Subjects with 
higher calcium intake had higher energy intake compare to subjects with low 
calcium intake tertile group (p = 0.037). 
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Table 2.4 Baseline characteristics according to calcium intake categories 
 Calcium Intake, No. (%) of Participants  
 Low (n=18) Mod. (n=19) High (n=19) All (n=56) p-value 
Calcium (mg), mean (SD) 726.8 (260.8) 1389.0 (167.9) 2286.7 (524.5) 1480.7 (730.5)  
Age, mean (SD), y 77.4 (9.3) 82.1 (10.3) 74.3 (8.7) 77.9 (9.8) 0.047 
Women  7 (38.9) 14 (73.7) 12 (63.2) 33 (58.9) 0.093 
Bachelor’s degree/higher 9 (50.0) 7 (36.8) 6 (31.6) 22 (39.3) 0.506 
White race 17 (94.4) 18 (94.7) 19 (100.0) 54 (96.4) 0.592 
Intervention group 7 (38.9) 11 (57.9) 13 (68.4) 31 (55.4) 0.194 
GDS 1.8 (1.5) 2.5 (2.0) 2.2 (1.6) 2.2 (1.7) 0.476 
MMSE 28.8 (1.8) 29.0 (1.0) 29.0 (1.2) 28.9 (1.3) 0.852 
Physical activity       
    Low activity 6 (33.3) 9 (47.4) 4 (21.1) 19 (33.9) 0.236 
    High activity 12 (66.7) 10 (52.6) 15 (79.0) 37 (66.1)  
Types of comorbidity      
    Heart disease  7 (38.9) 6 (31.6) 4 (21.1) 17 (30.4) 0.500 
    Diabetes  4 (22.2) 1 (5.3) 5 (26.3) 10 (17.9) 0.206 
    Cancer  4 (22.2) 6 (31.6) 5 (26.3) 15 (26.8) 0.815 
    Osteoarthritis  10 (55.6) 13 (68.4) 8 (42.1) 31 (55.4) 0.271 
    Depression  1 (5.6) 6 (31.6) 5 (26.3) 12 (21.4) 0.132 
    Lung disease  2 (11.1) 2 (10.5) 3 (15.8) 7 (12.5) 0.868 
Comorbidity      
   No comorbidity 4 (22.2) 4 (21.1) 5 (26.3) 13 (23.2) 0.901 
   1 comorbidity 5 (27.8) 3 (15.8) 4 (21.1) 12 (21.4)  
   ≥ 2 comorbidities 9 (50.0) 12 (63.2) 10 (52.6) 31 (55.4)  
 GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Exam  
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Table 2.5. Baseline physical performance and dietary characteristics according 
to calcium intake  
 
 
Calcium intake, No. (%) of Participants  
 Low (n=18) Mod. (n=19) High (n=19) All  (n=56) p-value 
      
AM-PAC, mean (SD)      
     Basic Mobility  56.3 (7.4) 55.4 (4.5) 57.7 (8.7) 56.5 (7.0) 0.589 
     Daily activity 58.2 (13.7) 59.9 (13.5) 58.4 (14.5) 58.8 (13.7) 0.920 
SPPB Score, mean (SD) 6.1 (2.8) 5.6 (2.6) 6.4 (2.7) 6.0 (2.7) 0.629 
Berg Balance, mean (SD) 40.3 (12.1) 40.5 (9.8) 44.1 (10.1) 41.6 (10.6) 0.471 
Strength, mean (SD), lb.     
     Fractured leg 29.4 (13.8) 23.6 (15.1) 25.6 (11.1) 26.1 (13.4) 0.439 
     Non-fractured leg 32.6 (13.6) 26.4 (15.4) 29.6 (10.6) 29.4 (13.4) 0.379 
Reaction time 280.8 (79.7) 280.7 (68.8) 322.6 (99.6) 295.0 (84.6) 0.220 
Calorie intake      
Total Calorie intake 1538 (459) 1933 (697) 1994 (512) 1826 (592) 0.037 
% cals protein 16.5 (3.5) 15.7 (2.6) 17.7 (4.6) 16.6 (3.7) 0.245 
% cals fat 30.2 (4.7) 29.3 (7.1) 30.8 (6.6) 30.1 (6.2) 0.771 
% cals carbohydrate 52.6 (7.5) 54.8 (7.9) 51.7 (7.1) 53.0 (7.5) 0.437 
 AM-PAC, Activity Measure for Post-Acute Care; SPPB, Short Physical Performance Battery. 
 
Table 2.6 shows the baseline physical performance characteristics and energy 
intake from the macronutrients according vitamin D intake. There were no 
significant differences in baseline characteristics across the tertile groups of 
vitamin D intake except in composite comorbidities (p = 0.033). 
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Table 2.6. Baseline characteristics according to Vitamin D intake categories 
      
 Vitamin D intake, No. (%) of Participants 
  
 Low (n=18) Mod. (n=19) High (n=19) All (n=56) p-value 
      
Vit. D (IU), mean (SD) 331.3 (154.6) 958.2 (280.5) 1627.8 (159.2) 983.9 (569.4)  
Age, mean (SD), y 79.3 (10.6) 78.5 (9.0) 76.1 (10.2) 77.9 (9.8) 0.600 
Women   10 (55.6) 11 (57.9) 12 (63.2) 33 (58.9) 0.892 
≥ Bachelor’s degree  8 (44.4) 7 (36.8) 7 (36.8) 22 (39.3) 0.865 
White race 16 (88.9) 19 (100.0) 19 (100.0) 54 (96.4) 0.117 
Intervention group  11 (61.1) 7 (36.8) 13 (68.4) 31 (55.4) 0.128 
GDS 2.0 (1.1) 2.1 (1.8) 2.5 (2.1) 2.2 (1.7) 0.592 
MMSE 29.0 (1.1) 28.8 (1.2) 28.9 (1.7) 28.9 (1.3) 0.938 
Physical Activity       
   Low activity 6 (33.3) 8 (42.1) 5 (26.3) 19 (33.9) 0.594 
   High activity 12 (66.7) 11 (57.9) 14 (73.7) 37 (66.1)  
Types of comorbidity      
   Heart disease  6 (33.3) 6 (31.6) 5 (26.3) 17 (30.4) 0.891 
   Diabetes  4 (22.2) 2 (10.5) 4 (21.1) 10 (17.9) 0.594 
   Cancer  3 (16.7) 6 (31.6) 6 (31.6) 15 (26.8) 0.507 
   Osteoarthritis  7 (38.9) 12 (63.2) 12 (63.2) 31 (55.4) 0.239 
   Depression  1 (5.6) 4 (21.1) 7 (36.8) 12 (21.4) 0.071 
   Lung disease  1 (5.6) 3 (15.8) 3 (15.8) 7 (12.5) 0.563 
Comorbidity      
   No comorbidity 8 (44.4) 2 (10.5) 3 (15.8) 13 (23.2) 0.033 
   1 comorbidity 3 (16.7) 7 (36.8) 2 (10.5) 12 (21.4)  
   ≥ 2 comorbidities 7 (38.9) 10 (52.6) 14 (73.7) 31 (55.4)  
 GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Exam  
 
Table 2.7 shows the baseline physical performance and caloric intake 
characteristics according to vitamin D tertile group. There were no significant 
differences among subjects across the tertile group in clinical characteristics and 
% of energy intake of macronutrients intake among subjects of vitamin D intake. 
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But the group with higher vitamin D intake also had higher % of energy intake 
from dietary protein 
Table 2.7. Baseline physical performance and dietary characteristics according 
to Vitamin D intake 
 Vitamin D intake, No. (%) of Participants 
 Low (n=18) Mod. (n=19) High (n=19) All (n=56) 
p-
value 
      
AM-PAC score, mean (SD)      
     Basic Mobility  56.6 (5.7) 57.0 (8.7) 55.8 (6.6) 56.5 (7.0) 0.871 
     Daily activity 59.0 (10.8) 60.8 (16.6) 56.7 (13.3) 58.8 (13.7) 0.655 
SPPB Score, mean (SD) 5.9 (2.5) 5.9 (2.9) 6.2 (2.8) 6.0 (2.7) 0.963 
Berg Balance Test, mean (SD) 40.6 (10.1) 40.5 (12.7) 43.7 (9.1) 41.6 (10.6) 0.581 
Leg strength, mean (SD), lb.          
     Fractured leg 26.0 (15.1) 26.3 (11.5) 26.0 (14.3) 26.1 (13.4) 0.997 
     Non-fractured leg 28.4 (15.7) 29.3 (12.2) 30.3 (12.9) 29.4 (13.4) 0.918 
Reaction time 278.1 (74.3) 291.3 (88.1) 314 (90.5) 295.0 (84.6) 0.419 
Calorie Intake      
Total calorie intake 1874 (645) 1696 (624) 1911 (511) 1827 (592) 0.498 
% calorie from protein 15.0 (2.7) 17.4 (4.5) 17.4 (3.2) 16.6 (3.7) 0.070 
% calorie from fat 31.1 (4.9) 28.5 (6.1) 30.6 (7.3) 30.1 (6.2) 0.409 
% calorie from 
carbohydrate 53.4 (7.7) 54.0 (6.8) 51.7 (8.1) 53.0 (7.5) 0.622 
AM-PAC, Activity Measure for Post-Acute Care; SPPB, Short Physical Performance Battery. 
 
Table 2.8 shows the baseline characteristics of subjects according to tertile groups 
of protein intake. Average protein intake of study subjects was 75 gm/day 
ranging from 48.5 gm/day to 102.8 mg/day across the tertile of protein intake. 
There were no statistically significant differences in baseline characteristics 
according to different groups of protein intakes.  
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Table 2.8. Baseline characteristics according to protein intake 
 Protein intake, No. (%) of Participants 
   Low n=18) Mod. (n=19) High (n=19) All  p-value 
Protein (gm), mean (SD) 48.5 (11.1) 72.2 (7.7) 102.8 (20.3) 75.0 (26.3)  
Age, mean (SD), y 76.9 (8.5) 77.4 (11.0) 79.4 (10.2) 77.9 (9.8) 0.734 
Female  10 (55.6) 9 (47.4) 14 (73.7) 33 (58.9) 0.248 
Bachelor’s degree or higher 6 (33.3) 8 (42.1) 8 (42.1) 22 (39.3) 0.824 
White race 17 (94.4) 19 (100.0) 18 (94.7) 54 (96.4) 0.592 
Intervention group 13 (72.2) 9 (47.4) 9 (47.4) 31 (55.4) 0.223 
GDS 2.2 (1.4) 2.3 (2.0) 2.1 (1.8) 2.2 (1.7) 0.929 
MMSE 28.8 (1.0) 28.9 (1.7) 29.0 (1.2) 28.9 (1.3) 0.931 
Physical activity       
    Low activity 9 (50.0) 5 (26.3) 5 (26.3) 19 (33.9) 0.223 
    High activity 9 (50.0) 14 (73.7) 14 (73.7) 37 (66.1)  
Types of Comorbidity      
    Heart disease  5 (27.8) 9 (47.4) 3 (15.8) 17 (30.4) 0.106 
    Diabetes  5 (27.8) 1 (5.3) 4 (21.1) 10 (17.9) 0.189 
    Cancer  3 (16.7) 7 (36.8) 5 (26.3) 15 (26.8) 0.389 
    Osteoarthritis   11 (61.1) 12 (63.2) 8 (42.1) 31 (55.4) 0.364 
    Depression  5 (27.8) 3 (15.8) 4 (21.1) 12 (21.4) 0.678 
    Lung disease  1 (5.6) 3 (15.8) 3 (15.8) 7 (12.5) 0.563 
Comorbidity      
   No comorbidity 4 (22.2) 3 (15.8) 6 (31.6) 13 (23.2) 0.644 
   1 comorbidity 5 (27.8) 3 (15.8) 4 (21.1) 12 (21.4)  
   ≥ 2 comorbidities 9 (50.0) 13 (68.4) 9 (47.4) 31 (55.4)  
 GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Exam 
Table 2.9 shows the physical performance and calorie intake from 
macronutrients according of protein intake group. Subjects with higher protein 
intake had also higher calorie intake, which was statistically significant 
(p<0.0001). The higher protein intake group had higher energy intake from 
protein, which was statistically significant (p=0.005) and also had lower energy 
intake from carbohydrate (p=0.025).  
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Table 2.9. Baseline physical performance and dietary characteristics 
according to protein intake  
      
 Dietary protein intake, No. (%) of Participants 
  
 Low (n=18) Mod. (n=19) High (n=19) All (n=56) p-value 
AM-PAC score, mean 
(SD) 
     
     Basic Mobility  56.2 (6.4) 57.6 (9.7) 55.7 (4.0) 56.5 (7.0) 0.696 
     Daily activity 60.0 (14.0) 59.8 (17.2) 56.8 (9.2) 58.8 (13.7) 0.728 
SPPB Score, mean (SD) 5.8 (2.7) 6.6 (3.0) 5.6 (2.2) 6.0 (2.7) 0.456 
Berg Balance, mean (SD) 40.3 (12.1) 42.5 (11.8) 42.1 (8.1) 41.6 (10.6) 0.802 
Leg strength, mean (SD), lb.          
     Fractured leg 27.0 (14.5) 27.4 (12.9) 24.0 (13.5) 26.1 (13.4) 0.708 
     Non-fractured leg 29.5 (14.6) 33.1 (12.8) 25.6 (12.5) 29.4 (13.4) 0.227 
Reaction time 295.6 (102.0) 284.9 (76.7) 304.4 (77.2) 295.0 (84.6) 0.782 
Calorie intake      
Total Calorie intake 1368 (380) 1756 (288) 2331 (606) 1827 (592) <0.000 
% of cals protein 14.6 (2.9) 16.8 (2.6) 18.4 (4.4) 16.6 (3.7) 0.005 
% of cals fat 29.5 (6.9) 29.0 (5.5) 31.7 (6.2) 30.1 (6.2) 0.378 
% of cals carbohydrate 55.2 (7.6) 54.7 (7.0) 49.3 (6.8) 53.0 (7.5) 0.025 
AM-PAC, Activity Measure for Post-Acute Care; SPPB, Short Physical Performance Battery. 
 
Tables 2.10, 2.11, and 2.12 show the associations between calcium, vitamin D, and 
dietary protein intake and physical functioning outcomes, respectively. Since 
these analyses are independent of randomization status, we controlled for age, 
sex, and treatment group due to between-group differences.  In Table 2.10 we see 
that those with the highest calcium intakes tended to have greater improvements 
in some of the functional performance scores, including the mobility score, the 
SPPB, and the Berg Score. They also gained the most strength in both the 
fractured and non-fractured leg and had the greatest improvements in reaction 
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time. None of these results were statistically significant but the trend was 
apparent.  
Table 2.10. Cross-sectional and prospective association between baseline 
calcium intake and functional performance  
 
Calcium Intake Tertiles 
 
 
Mean Baseline Study Outcome 
Mean Change from Baseline to 6 
months 
Study Outcomes N  High  Medium Low N  High  Medium Low 
 
Overall  Adjusted Means1 Overall  Adjusted Means 
AMPAC 
          Basic Mobility 56 57.1 58.0 55.5 48 1.4 1.5 1.0 
p-value2 
 
p=0.52 
 
p=0.94 
   Daily Activity 56 57.6 64.4 56.8 48 1.4 -0.7 4.3 
p-value2 
 
p=0.18 
 
p=0.36 
SBBP 56 5.9 6.7 5.8 48 1.2 0.5 0.7 
p-value2 
 
p=0.35 
 
p=0.29 
Leg strength 
          Fractured 54 26.7 30.0 25.8 45 7 3.9 2.1 
p-value2 
 
p=0.48 
 
p=0.33 
  Nonfractured  54 30.6 32.6 29.1 45 2.7 0.3 -0.4 
p-value2 
 
p=0.64 
 
p=0.61 
Berg Score 56 42 44.7 39.3 48 1.4 -0.6 0.2 
p-value2 
 
p=0.17 
 
p=0.35 
Reaction time (msec) 56 325.1 254.6 290 48 -28.1 -3.0 -4.1 
        p-value2 
 
p=0.04 
 
p=0.48 
 1 Adjusting for treatment assignment, age, and sex 
 2 P-value for overall differences across categories of calcium intake 
 
Results shown Table 2.11 indicate no consistent trends associated with vitamin D 
intake and functional performance scores. And, again, in Table 2.12 we see no 
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association between tertiles of protein intake and change in physical functioning 
outcomes from baseline to 6 and 9-month follow-up period.   
 
Table 2.11. Cross-sectional and prospective association between baseline 
Vitamin D intake and functional performance 
 
 Vitamin D Tertiles of Intake 
  Mean Baseline Study Outcome 
Mean Change from Baseline to 6 
Months 
Study Outcomes N  High  Medium  Low N  High  Medium Low 
    Adjusted Means1   Adjusted Means1 
AMPAC 
   
		
	   
		
  Basic Mobility 56 55.6 57.6 57.2 48 -0.36 2.5 1.6 
p-value2   p=0.57   p=0.14 
   Daily Activity 56 56.5 61.7 59.9 48 -1.0 3.4 3.0 
p-value2   p=0.47   p=0.37 
SBBP 56 6.0 6.1 6.3 48 0.6 1.1 0.6 
p-value2   p=0.90   p=0.59 
Leg strength      
  
 
  Fractured 54 28.1 27.4 26.9 45 3.1 3.7 5.5 
p-value2   p=0.94   p=0.72 
  Nonfractured  54 32.4 30.3 29.5 45 -0.3 -0.02 2.4 
p-value2   p=0.66   p=0.62 
Berg Score 56 43.0 41.0 41.8 48 -0.6 0.5 0.9 
p-value2   p=0.77   p=0.44 
Reaction time (msec) 56 310.2 290.9 269.4 48 -14.6 -8.0 -10.3 
        p-value2   p=0.32   p=0.96 
 
1 Adjusting for treatment assignment, age, and sex 
2 P-value for overall differences across categories of vitamin D intake 
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Table 2.12. Cross-sectional and prospective association between baseline 
protein intake and functional performance  
 
 Dietary Protein Tertiles 
  Mean Baseline Study Outcome 
Mean Change in Study Outcome 
from Baseline at Month 6 
Study Outcomes N  High  Medium  Low N  High  Medium Low 
    Adjusted Means1   Adjusted Means1 
AMPAC   
   
  
  
  
  Basic Mobility 56 57.2 57.3 55.9 48 -0.1 1.2 2.7 
p-value2   p=0.75   p=0.20 
   Daily Activity 56 59.1 59.3 59.9 48 -0.2 3.5 1.9 
p-value2   p=0.98   p=0.58 
SBBP 56 6.0 6.5 5.7 48 1.1 0.7 0.7 
p-value2   p=0.51   p=0.71 
Leg strength   
   
  
  
  
  Fractured 54 29 26.7 26.8 45 2.7 6.7 2.2 
p-value2   p=0.74   p=0.25 
  Nonfractured  54 30.2 32.5 29.3 45 0.7 0.9 0.5 
p-value2   p=0.62   p=0.99 
Berg Score 56 43.9 42.1 39.7 48 0.3 -0.4 1.1 
p-value2   p=0.32   p=0.54 
Reaction time (msec) 56 293.7 287.8 289.7 48 -29.2 -6.9 1.1 
        p-value2   p=0.98   p=0.43 
 
1 Adjusting for treatment assignment, age, and sex 
2 P-value for overall differences across categories of protein intake 
 
 
2.6 Discussion of the main study 
This randomized controlled trial found that the HIP Rehab program significantly 
improved function after formal hip fracture rehabilitation ended. Improvements 
in basic mobility function, and in the performance of daily activities, were 
clinically and statistically meaningful. The impact of the exercise program on 
function was durable, as the effect on all functional outcomes persisted for three 
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months after the 6 months of the active intervention ended. This is the first 
randomized controlled trial to find an impact on overall function after hip 
fracture with a home-based program that required minimal contact from a 
physical therapist. 
Unlike previous studies that have found a significant capacity for people with 
hip fracture to improve after usual rehabilitation has ended (107, 108), the HIP 
study was home-based, meaning that it is much more feasible to incorporate the 
findings of this trial into current rehabilitation protocols.  In HIP study, there was 
no need for participants to travel outside their home or to utilize expensive 
exercise equipment. The study did not require a team of people, but was 
delivered by one physical therapist and the level of contact with the physical 
therapist was modest.  Despite their substantial functional and balance 
limitations at baseline, subjects were able to perform HIP Rehab effectively on 
their own.   
In addition to the lower frequency and intensity of supervision, HIP Rehab 
differed from other studies in several ways.  This program included a very well-
developed cognitive-behavioral component, which previous studies indicated 
was necessary to achieve adherence in a home-based program with limited 
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supervision (109, 110). HIP Rehab contained functionally oriented exercises, 
rather than exercises that focused on basic strength impairments. The stepping 
exercises were developed based on studies that had found some impact on 
function in people with hip fracture and in frail older adults (111, 112). The 
activities focused on tasks that have been found to be limited for many people 
two years after hip fracture, such as standing up from a chair or climbing steps 
(76). The principle of the specificity of training suggests that more directly 
training functional tasks might lead to better functional outcomes.  This training 
approach might be one reason for our impact on function and balance, while the 
changes in strength were more modest, and only statistically significant in the 
non-fractured leg.   
The findings of this trial are robust because function was measured in a 
comprehensive way, using both patient-reported and physical performance 
measures, and examined relevant basic mobility and complex daily activity 
functions important to the lives of older people. It has been established that self-
report and performance based functional outcomes measure similar but distinct 
aspects of function (113). Therefore, finding significant changes in almost all 
aspects of function measured provides consistent evidence that a true change in 
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overall function took place in the HIP Rehab group. The high level of 
comorbidity and functional limitation at baseline are consistent with the general 
population of hip fracture patients, and suggest that these results should have 
strong generalizability.  
There are some limitations to this project. Despite rigorous efforts to obtain data 
from all study participants, some loss to follow-up did occur. However, 
significant between-group differences persisted when missing data was 
accounted for in the analyses. Loss to follow-up is actually low for a trial of hip 
fracture patients, who due to their frequent comorbid illnesses, re-
hospitalizations and transitions in their home environments are a challenging 
population to maintain (114). These findings have important policy relevance. 
The current approach to rehabilitation for hip fracture leaves many people with 
long-term functional limitations that could be reduced with extended 
rehabilitation. However, it is unlikely that additional months of highly 
supervised rehabilitation can be provided to people with hip fracture. Medicare 
spending on post-acute care for hip fracture doubled from 1994–2009, with post-
acute care accounting for 73% of the growth of all Medicare expenditures for hip 
fracture (115). Outpatient therapy services cost Medicare over $5.7 billion in 2011, 
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with 70% of those payments going to physical therapy outpatient services (116). 
These outpatient therapy costs have increased by an average of 4% per year in 
the past decade (116), despite various attempts to contain costs (117). 
The spiraling costs of post-acute care combined with evidence that people would 
benefit from additional therapeutic exercise suggest that alternative strategies are 
needed. Outpatient physical therapy services are typically delivered in discrete 
short-term episodes and include a limited number of visits (118). After an 
episode is completed, the patient is discharged with a written home exercise 
program with instructions to carry out this program independently on an 
ongoing basis. Exercise programs are challenging for people to perform on their 
own without clear feedback about whether they are performing the exercises 
accurately and safely and without guidance as to how to change the exercises 
over time. The Hip Rehab program provides a promising new approach to 
discharging people from traditional rehabilitation. HIP Rehab could be 
introduced to patients in their final sessions of physical therapy, and provide a 
more effective way for people to continue to exercise in their own homes. 
Future research should explore whether this program can be cost-effectively 
disseminated in real clinical environments. Tele-health and mobile health 
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technologies offer the potential for more support and communication to 
efficiently occur between therapist and patient and for automated content to 
provide enhanced motivational content and program adaptability (119, 120). To 
date, there has been limited application of these technologies to rehabilitation 
populations (121) but they could provide an efficient and effective way to widely 
disseminate this program. 
In conclusion, home-based functionally-oriented exercises that required minimal 
in-person contact from a physical therapist successfully extended the functional 
recovery of older adults who had completed their hip fracture rehabilitation.  
Clinically meaningful change was observed in both a basic mobility 
performance-based functional test and in a self-report measure of daily activities. 
The effect persisted three months after the intervention ended. 
2.7. Discussion of the pilot study  
Additional analyses were conducted on a subsample (n=56) of the original 232 
subjects in the HIP study to evaluate the effects of usual intakes of calcium, 
vitamin D, and dietary protein on the same measures of physical and functional 
performance. All three nutrients were associated with greater improvements in 
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reaction time. However, only calcium intakes was linked with consistent 
improvements in functional performance scores and strength.  
Since the hip fracture subjects in this study had baseline physical functioning 
information collected up to 20 months after discharge from the rehabilitation 
services and since they may already had been advised to modify their diets to 
include adequate intakes of dietary protein, vitamin D, and calcium after 
sustaining their hip fractures, it was understood that this small study might be 
underpowered to detect any effect. However it served as a valuable pilot study 
that gave me experience in assessment of nutrient intakes and in carrying out the 
statistical analyses that helped prepare me for the study described in chapters 3 
and 4.   
Vitamin D has been shown to protect against fractures by promoting calcium 
homeostasis and increasing bone mineral density (BMD) (122–126). Studies also 
indicate that vitamin D is linked to muscle strength and function (57, 63, 88, 127, 
128) through several mechanisms. Vitamin D facilitates de novo protein 
synthesis (57) in skeletal muscle by its action on nuclear receptor VDR in muscle 
tissue (129, 130). Vitamin D has also been shown to increase the size and number 
of type II muscle fibers which are directly related to physical functioning (131, 
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132). However, prior studies showed that the combined intakes of vitamin D and 
calcium may be important to physical functioning. We were not able to examine 
the combined effects in this pilot study due to limited power. 
Another limitation of the current study is that we do not have data on vitamin D 
status (25(OH)D). Since sun exposure is the primary determinant of vitamin D 
status, it is likely that this population of older individuals following hip fracture 
would spend little time out in the sun. Therefore, it is possible that the 
prevalence of vitamin D deficiency may be high. In the LASA study in 
Amsterdam, approximately 50% of adults over 65 years of age had vitamin D 
levels < 20 ng/ml at baseline. That study found that subjects with lower vitamin 
D status at baseline had greater physical functioning decline over 3 years [OR = 
2.21 (1.00–4.87) compared with subjects whose 25(OH)D was at least 30 ng/ml] 
(59). Other studies have shown that lower vitamin D status was associated with 
poorer grip strength and other adverse health outcomes (133). Data from both 
the Health ABC study and the Rancho Bernardo Study found that low vitamin D 
status in adults in their 70s was associated with more physical limitation, poorer 
physical performance scores  and more disability (64, 134). However, some 
studies had found no association between vitamin D and physical functioning 
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outcomes (135–140).  
Dietary protein is believed to play a major role in musculoskeletal health. The 
bone matrix contains important collagenous and non-collagenous protein (14). 
The mechanism by which dietary protein may help in the maintenance of 
musculoskeletal health is through IGF-I (15) and the rapamycin (mTOR) 
signaling cascade (30). Prior studies showed that dietary protein was associated 
with muscle mass, strength, physical functioning, and health outcomes (32, 141–
144).  
The current study was relatively short-term (9 months) and it may be that longer-
term studies are needed to see the effects of protein intake on physical 
functioning among older adults. The analyses for the pilot component of this 
study were not based on the randomized design, which may have resulted in 
uncontrolled confounding. In addition, the participants who were in the control 
group had a nutrition-based intervention, which could have biased the reporting 
of protein in particular (since the focus was cardiovascular health). In the future, 
it will be important to carry out randomized controlled trials of these questions 
as well as longer-term follow-up studies to assess the effects of dietary protein on 
physical functioning among older adults recovering from hip fracture.   
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CHAPTER THREE: DIETARY PROTEIN PREVENTS LOSS OF PHYSICAL 
FUNCTIONING AMONG MIDDLE-AGED AND OLDER ADULTS IN THE 
FRAMINGHAM OFFSPRING STUDY 
3.1. Background 
Protein makes up 80% of skeletal muscle mass in the human body (145). It plays 
a vital role in maintaining cellular function and structure. With aging, muscle 
mass begins to decline at 1% per year from the peak between 20 to 30 years of 
age; this loss of muscle mass accelerates starting at about age 50 years, 
particularly in relation to physical functioning involving the lower extremities 
(146). Lean muscle mass declines from 50% of total body weight in young adults 
to 25% in older adults (75–80 years) (145). 
Anabolic stimuli for muscle protein synthesis are activated by the mammalian 
target of rapamycin (mTOR) signaling cascade (30).  In human muscle protein 
synthesis, feeding is associated with enhanced phosphorylation and activation of 
the mTOR signaling pathway, which includes 70-kDa ribosomal protein S6 
kinase (S6K1) and its target ribosomal protein S6 (rpS6). Protein synthesis is 
tightly regulated by the activation of guanine nucleotide exchange factor 
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eukaryotic initiation factor 2B (elF2B), which is responsive to amino acid intake 
and controlled by glycogen synthase kinase-3b (30). 
Loss of lean muscle mass during aging leads to muscle weakness which further 
leads to the risk of falling, fractures, restricted mobility, decline in physical 
functioning, loss of independence and reduced life expectancy (147).  Lean 
muscle mass and bone health are closely linked. Lean muscle mass provides 
mechanical force on bone to improve bone density, strength and 
microarchitecture (147). A combination of bone and muscle health is key to 
optimal physical functioning. The current recommended dietary allowance 
(RDA) for protein intake in the USA is 0.8 gm/kg/day for adults. This dietary 
guideline was derived largely from studies based on nitrogen balance. Nitrogen 
balance studies are conducted generally for only short periods of time (between 
10–15 days), which may not be sufficient to detect optimal functioning of muscle, 
bone, and connective tissues (148, 149). In addition, most nitrogen balance 
studies are conducted among young adults. One recent meta-analysis of nitrogen 
balance studies, for example, included only one study with only 16 older subjects 
of the total sample of 235 individuals (148). In one nitrogen balance study of 
elderly adults, investigators found that the protein requirement of elderly adults 
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would be 1.0–1.25 g/kg/d of high-quality protein (150). 
Some data are emerging that suggest that for older people to maintain muscle 
mass and optimal physical functioning, greater amounts of dietary protein may 
be required. It is increasingly recognized that the dietary recommendations for 
protein intake in older adults should be focused on their unique needs for 
maintaining lean muscle mass, physical functioning, and muscle strength. Older 
adults tend to become resistant to anabolic stimuli such as consuming protein-
source foods or doing resistance exercise for protein synthesis, thereby resulting 
in loss of skeletal muscle mass (151). Cuthbertson et al. in their experiment found 
that older subjects had diminished effects on the mammalian target rapamycin 
(mTOR) signaling pathway for protein synthesis after ingestion of 10 g essential 
amino acids (EAA) (152). Leucine, a branched chain amino acid, is a key anabolic 
stimulator that activates the mTOR nutrient signaling pathway that stimulates 
postprandial muscle protein synthesis (153, 154). Decline of lean muscle mass can 
be reversed by consumption of protein and/or amino acids in addition to 
resistance exercise, both by stimulating muscle protein synthesis and inhibiting 
protein breakdown, resulting in positive net protein balance even as we age 
(155).  
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In contrast with the current protein recommendation for US adults of 0.8 
g/kg/day, one international expert panel recommended protein intake of 1.0 – 1.2 
g/kg per day for older adults (65 years and above), with an even higher intake 
recommended for older adults who exercise and are more active (156). Many 
researchers agree that the current US dietary recommendation of 0.8 gm/kg/day 
for middle-aged and older adults may not be adequate to maintain lean muscle 
mass. A review by Volpi et al concluded that to retain muscle mass, strength and 
optimal physical functioning among the older adults, the current 
recommendation for dietary protein intakes for older adults of 0.8 g/kg/day 
should be raised (157).  The rationale for this recommendation is that during the 
middle-aged and older adult years, there are changes in body composition and 
lifestyle resulting in lower lean mass and in many cases higher fat mass and this 
transition is likely to be associated with a higher risk of functional decline and 
increased morbidity and mortality (158–160).  
Despite the growing belief that dietary protein intakes in older adults should be 
raised, there are a few studies demonstrating that higher intakes (>0.8 
gm/kg/day) are associated with better health outcomes among middle-aged and 
older adults. After 3 years of follow-up in the Health, Aging, and Body 
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Composition (Health ABC) study those in the highest quintile of protein intake 
(vs. lowest quintile) had a 40% less decline in lean mass (LM) and appendicular 
lean mass (aLM) (32). A few other longitudinal studies also found that higher 
intakes of protein can reduce age-related muscle loss (141, 142). One prospective 
study with a follow up of 10 years among women with a mean age of 72 years 
found that those with higher intake of protein (1.20 – 1.76 g/kg/day) tended to 
have fewer health problems compared with those who had lower protein intakes 
(0.8 – 1.2 g/kg/day) (161). Data from the Women’s Health Initiative, a prospective 
study of 24,000 women, aged 65 to 79 years, also found that those with higher 
protein intakes (20% of energy from protein) had a 32% lower risk of frailty after 
3 years of follow-up (143). Finally, in a clinical trial study over 24 weeks among 
frail elderly people, subjects with dietary protein supplement (30 g) (vs. placebo) 
had improved in leg extension strength, physical performance (SBBP). But in this 
study there were no changes in muscle mass including type 1 and type 2 muscle 
fiber size (144). But with resistance-type exercise training, protein 
supplementation among frail elderly subjects led to increased muscle mass in 
addition to muscle strength and physical performance in a clinical trial (162). 
While the above studies suggest that higher intakes of dietary protein prevent 
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greater age-related decline of muscle mass, at least short term, many such studies 
suggest that the greatest anabolic stimulus results from the combination of 
higher intakes of dietary protein with resistance exercise (163–165). Finally, there 
is very little evidence addressing the question of whether dietary protein intake 
may modify the beneficial effects of an active lifestyle on physical functioning 
among middle-aged and older adults over time. Data from long-term 
longitudinal studies such as the Framingham Studies may help to shed light on 
the question of whether the current Dietary Guidelines for protein intake for older 
adults are sufficient to meet their metabolic and physiologic needs. Such 
evidence from long-term studies is particularly important since many older 
adults already fail to meet the current RDA for protein of 0.8 g/kg/day due to 
multiple age-related factors.  
We propose that recommendations for the level of adequate dietary intake of 
protein in older adults should be informed by evidence derived from functional 
outcomes. However, such longer-term prospective evidence to assess the effect of 
dietary protein on lean muscle mass and functional outcomes among middle-
aged and older adults is lacking. The objective of our study is to examine the 
independent effects of dietary protein intakes above the current RDA on long-
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term changes in physical functioning over more than a decade among initially 
middle-aged and older adults in the Framingham Offspring Study and to 
determine whether the protein-related effects on functional status are modified 
by physical activity, BMI, or skeletal muscle mass (SMM).   
3.2 Study design 
Study population  
The Framingham Heart Study started in 1948 with 5,209 male and female 
subjects randomly recruited from the town of Framingham, MA. A second- 
generation study, the Framingham Offspring Study (FOS), was begun in 1971 
with the recruitment of the original participants’ adult children and their spouses 
(n = 5,124). After a second examination visit in 1980 eight years after enrollment, 
FOS subjects were examined every four years at the Framingham Heart Study 
Clinic in Framingham.  
For our analyses of FOS subjects, we included 1894 subjects (men=891, 
women=1003) who met the following eligibility criteria: 1.) age at least 50 years 
old at exam 3, 4, or 5 (baseline for these analyses), and 2.) responded to all of the 
following seven selected functional task questions derived from the Rosow-
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Breslau and Nagi scales: heavy work around the house; walking up and down 
stairs; walking half a mile; pulling or pushing large objects; stooping, crouching, 
or kneeling; lifting or carrying weights under 10 pounds; lifting or carrying 
weights over 10 pounds.  
Subjects were excluded from these analyses based on the following criteria: 1.) 
did not attend exams 3, 4 or 5 (n= 740); 2.) provided no food diary data (n = 1100); 
3.) reported extreme energy intakes (for men, < 1200 calories or > 4000 calories 
per day; for women, < 1000 calories or > 3500 calories per day) (n = 322); 4.) were 
less than 50 years old at exams 3, 4, and 5 (n = 868);  5.) did not attend exams 5, 6, 
7 and 8 when functional status data were collected (n = 119); 6.) had a diagnosis 
of prevalent cancer (except non-melanoma skin cancer) at time of baseline 
functional assessment (n =71);  7.) incomplete or missing functional variables (i.e., 
the 7 selected tasks derived from Rosow-Breslau and Nagi Scales) at exams 5, 6, 7 
and 8 (n = 10). Based on these inclusion and exclusion criteria, a total of 3230 
subjects from the Framingham Offspring Study were excluded from the total 
5,124 FOS subjects, leaving a subset of 1894 subjects for our analyses. This 
number included 891 men and 1003 women.  
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Dietary assessment  
FOS subjects’ dietary data were recorded using 3-day diet records following 
standardized procedures and supervised by a trained nutritionist in exam 3 cycle 
(1984–1988) and exam 5 cycle (1991–1995). Subjects completed the 3-day diet 
record using 2 dimensional food models to aid in the estimation of dietary 
portion sizes. To derive the daily intake of nutrients including dietary protein, 
each subject’s 3-day dietary records were analyzed using the Nutrition Data 
System (NDS), a nutrient calculation program developed by University of 
Minnesota (167). 
Each subject’s dietary protein intake was expressed in two ways to account for 
potential confounding by overall body size: 1.) protein intake in standard gm/kg 
of body weight per day and 2.) weight-adjusted sex-specific protein intakes (gm 
per day) derived from subject-specific linear regression models. The latter 
method used weight-adjusted protein intake residuals from a regression model 
to remove variation in intake due to body weight. That is, protein intakes were 
regressed on each subject’s body weight to compute the protein residual which 
represents the difference between the actual protein intake of the subjects and the 
intake predicted by their body size. The resulting protein residual is uncorrelated 
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with body weight thus allowing the variation due to protein intake to be 
evaluated directly.  
Functional status outcome assessment  
Data on the functional status of FOS subjects were collected routinely at every 
exam cycle. Two well-validated scales were employed for this purpose: 1) Nagi 
scale (168) (a self-reported functional status scale consisting of 11 items scored on 
a 0–5 range); 2) Rosow-Breslau scale (169) (a self-reported scale to measure the 
functional status on gross-mobility tasks with 6 items questionnaire scored on a 
0–1 range).  
For this study, we selected seven specific tasks measured by the Rosow-Breslau 
and Nagi scales at exams 5 through 8. Specifically, these seven tasks were ones 
that were particularly related to the strength and endurance that underlie the 
functional status. The three tasks selected from Rosow-Breslau Scale included 
heavy work at home (like shoveling, washing windows, walls or floors), walking 
1/2 mile (about 4–6 blocks), and going up and down a flight of stairs. Subjects 
were asked to report their ability to do these tasks independently; those using a 
cane or other assistive device were considered independent as long as they did 
not require assistance from another person. The four tasks selected from Nagi 
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Scale included pushing/pulling heavy objects (like a living room chair), stooping, 
kneeling, and crouching, lifting <10 pounds (like a bag of potatoes) and lifting>10 
lbs (a very heavy bag of groceries). Subjects’ responses on these 4 functional tasks 
were scored as 0=no difficulty, 1=a little difficulty, 2=some difficulty, 3=a lot of 
difficulty, 4=unable to do). These responses were further collapsed to a 
dichotomous outcome as follows: able to do (categories 0, 1, or 2) vs. unable to do 
(categories 3 and 4). 
Assessment of potential confounders and effect modifiers 
Subjects’ baseline age, sex, and education were included as potential 
confounders. Education level was categorized as college graduate or less 
education. Subject’s weight and height were measured to the nearest 0.25 pound 
and to the nearest 0.25 inch, respectively, using a standard counterbalance scale 
with a measuring bar.  
We used the individual’s weight at baseline and the average adult height (ages 
18–60 for women and ages 21–60 for men) to calculate exam-specific BMIs as 
weight in kg divided by height in meter squared. The use of mean height will 
help to reduce measurement errors and the effect of height loss after age 60.  
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Cigarette smoking information was collected routinely at every examination to 
assess subjects’ current and past smoking status as well as total pack-years. 
Subjects who smoked at least one cigarette per day were considered as current 
smokers. In our study, subjects’ smoking status was reported as number of 
cigarettes smoked per day.  
Information on alcohol intake was also collected routinely. This self-reported 
data included drinking status (e.g., current or past drinker, abstainer, abuser), 
drinking frequency (lifetime abstainer, past drinker, occasional drinker, regular 
drinker), and drinking amount (light, moderate, heavy). In our study, subjects’ 
drinking status was reported as gm per day of alcohol intake.  
Physical activity was assessed by self-report at exams 2 and 4. A history of usual 
activity was recorded from each subject’s number of hours a day spent in sleep, 
sedentary activities, physical activity (light, moderate, and vigorous) in a 24 hour 
period. A composite score, the physical activity index, was derived by summing 
the product of the hours at each level of activity (which includes moderate and 
vigorous activities) times a weight based on the estimated energy expenditure 
(oxygen consumption) required for that activity. In order to derive the final 
physical activity index, a weight factor of 2.4 was used to reflect the oxygen 
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consumption required for a moderate level of activity and a weight factor of 5 
was used to reflect the oxygen consumption required for more vigorous activity 
(170). We used the average physical activity index from exams 2 and 4 as an 
indicator of usual baseline activity.  
Each subjects’ skeletal muscle mass (SMM) was determined using the Janssen et 
al equation (171) as follows:  
SMM (kg) = [(Height2 / BIA-resistance x 0.401) + (Sex x 3.825) + (Age x -0.071)] + 
5.102 
where height is in cm; BIA-resistance is in ohms; sex is coded men=1 and 
women=0; and age is in years. Absolute skeletal muscle mass (kg) was then 
converted to percentage skeletal muscle mass and termed skeletal muscle index 
(SMI) as follows: 
SMI (%SMM) = skeletal muscle mass / body mass * 100  
Subjects were considered to have a normal SMI if their SMI was within one 
standard deviation below the sex-specific mean for young adults (ages 18–39). 
We used the sex-specific mean SMI for young adults calculated by Janssen and 
colleagues as reference because of a higher number of subjects in their 
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population (n= 3298 women and 3116 men). The mean SMI (%SMM) in 18–39 
year old men was 42.5% ± 5.5% while in women of the same age range it was 
33.1% ± 5.5%. In our study, low %SMM was considered as <36 for men and <26 
for women. High %SMM was considered as ≥36% for men and ≥26% for women 
according to sensitivity analysis.  
 
Statistical analysis 
There are two analytical aims for this study: 1.) to estimate the independent effect 
of dietary protein intake on functional outcomes in FOS subjects, aged 50 and 
above; 2.) to determine whether BMI, physical activity, and skeletal muscle mass 
(SMM) modify the effect of dietary protein on functional status over time.  
For these analyses, dietary protein was categorized in two ways: 1.) protein 
expressed as gm/kg/day and classified as <0.8, 0.8–<1.2, and ≥1.2 gm/kg/day; and 
2.) protein expressed as gm/day (calculated using weight-adjusted residuals) and 
classified as sex-specific quintiles of intake.  
For each of the seven selected functional tasks from the Rosow-Breslau and Nagi 
scales, subjects were classified as “able to do / independent” or “unable to do / 
dependent”. 
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The Rosow-Breslau Scale tasks (e.g., heavy work around the house) entail 
dichotomous responses (the subject responds either “can do” or “can’t do”). 
Thus, these responses were used to classify subjects directly as dependent 
(unable) or independent (able). For the Nagi scale, there were 5 possible response 
categories. For these analyses, the categories were collapsed to reflect whether 
the subject was independent or dependent. Those who responded that they had 
“a lot of difficulty” or were ”unable to do” a particular task were considered 
dependent while subjects who responded “no difficulty”, “a little difficulty” or 
“some difficulty” were considered independent on those tasks.  
For most analyses, we included subjects who were independent in the 7 selected 
tasks at exam 5 who were followed prospectively through exam 8 to estimate the 
incidence of functional decline in each protein intake group over time. 
To assess the overall risk of functional decline, we also created a weighted 
composite score based on the 7 selected tasks from the Rosow-Breslau and Nagi 
scales. These tasks were weighted on the basis of the level of strength and/or 
endurance needed to complete the task. The Rosow-Breslau Scale tasks were 
scored as follows: (a) heavy work around the house (washing windows walls or 
floors, shoveling) - 0 points for unable, 4 points for able; (b) able to walk up and 
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down stairs to second floor - 0 points for unable, 3 points for able; and (c) able to 
walk half a mile (about 4–6 blocks) – 0 points for unable, 4 points for able. For the 
Nagi Scale, the tasks were scored as follows: (a) pulling or pushing large objects 
(e.g. living room chair) – 0 points for unable, 1 for a lot of difficulty, 2 for some 
difficulty, 3 for a little difficulty, and 4 points for no difficulty; (b) stooping, 
crouching, kneeling - 0 to 4 points as for previous task; (c) lifting or carrying 
weights under 10 pounds (bag of potatoes) - 0 points for unable, 0.5 points for a 
lot of difficulty, 1 for some difficulty, 1.5 points for a little difficulty, and 2 points 
for no difficulty; and (d) lifting or carrying weights over 10 pounds (heavy bag of 
groceries) – 0 to 4 points as before. The total functional score (ranging from 0 to 
25 points) was the sum of points for all 7 tasks from the two scales. 
The baseline characteristics of subjects according to dietary protein intake at 
exams 3 and 5 were compared using means and proportions across groups. The 
univariable associations between dietary protein intakes (low, moderate, high 
intake categories) and prevalence of functional disabilities were analyzed using 
Mantel Haenszel chi-square analyses. Incidence rates of physical dysfunction 
were calculated as the number of functional disabilities divided by the total 
person-time of follow up in each protein intake group. Person-time in each group 
was calculated as time from the final measurement of dietary protein intake to 
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the first of the following events: 1.) date of development of disability in any of 
the specific tasks of interest; 2.) lost to follow-up; 3.) death; or 4.) end of data 
collection period for this study (exam 8). The relative risk of functional disability 
among those with different levels of protein intake was calculated as the 
incidence rate in the moderate and high protein intake groups divided by the 
incidence rate in low protein group (reference group). 
To determine the adjusted relative risks associated with moderate and high 
protein intakes, Cox proportional hazards models were used. To examine the 
change in the functional status score by protein intake group from exams 5 to 8, 
we used repeated-measures longitudinal mixed models.  
To assess effect modification of protein intake on functional outcomes by BMI, 
BMI was categorized as ≥28 vs. <28 and cross-classified with dichotomous 
protein intake. Dietary protein intake was dichotomous as “Low Protein” (lowest 
sex-specific quintile of weight adjusted protein) and “High protein” as upper 
four sex-specific quintiles using protein residual method.  
Similarly, protein intake was cross-classified with dichotomous physical activity 
level (categorized as the lowest two sex-specific quintiles of activity vs. the upper 
three quintiles of activity). Lastly, effect modification by SMM was examined 
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after SMM was dichotomized as “Low %SMM” vs. High %SMM. In our study, 
low %SMM was considered as <36 for men and <26 for women. High %SMM 
was considered as ≥36% for men and ≥26% for women according to sensitivity 
analysis.   
All statistical analyses were carried out using SAS 9.3 program.  
3.3. Results 
Table 3.1. shows the baseline characteristics of subjects according to three 
categories of protein intake: <0.8, 0.8–<1.2, and ≥1.2 gm/kg/day. There were a 
total of 1894 subjects (men 891, women 1003), with average age of 56 years at 
baseline. Subjects in the higher protein intake categories had a lower weight and 
lower BMI than those in the lowest category of protein intake. Subjects 
consuming ≥1.2 gm/kg of protein per day were more physically active than those 
in the lower two protein categories. In terms of nutrient intakes, subjects with the 
highest protein intakes consumed more energy and a lower percent of energy 
from carbohydrates as well as had higher amounts of calcium and vitamin D 
compared with subjects in the lowest protein intake category. Fewer subjects in 
the lowest protein category were college graduates; they were slightly more 
likely to be living alone and reported slightly higher use of anti-depressant 
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medications compared to subjects with higher protein intakes. 
Table 3.1. Baseline characteristics by categories of protein intake 
  Protein Intake Category (g/kg/day) 
Characteristics <0.8 g/kg 0.8–<1.2 g/kg ≥1.2 g/kg   
  n= 380 n=1006 n=508 p-value1 
  mean (s.d.) 
Age (yrs) 56.6 (6.3) 56.7 (5.9) 56.2 (5.6) 0.2495 
Height (cm) 167.9 (9.7) 167.6 (9.3) 166.8 (9.2) 0.1558 
Weight (kg) 86.2 (17.9) 75.6 (14.4) 69.61 (12.6) <.0001 
BMI (kg/m2) 30.5 (5.5) 26.8 (3.9) 24.9 (3.3) <.0001 
Physical Activity Index 12.8 (8.8) 12.5 (8.5) 13.7 (9.0) 0.0289 
Cigarettes/day 4.0 (9.9) 3.5 (9.2) 4.2 (10.5) 0.3647 
Alcohol intake 
(gm/day) 9.2 (18.8) 10.8 (15.3) 12.8 (17.9) 0.0067 
Nutrient Intakes         
  Protein (% kcals) 16.0 (3.4) 17.1 (3.1) 18.1 (3.0) <.0001 
  Fat (% kcals) 34.1 (6.3) 34.4 (6.6) 34.6 (6.6) 0.4812 
  Carbs. (% kcals) 48.7 (8.1) 46.7 (7.9) 45.6 (7.6) <.0001 
  Calcium (mg) 553.4 (203.4) 684.7 (253.1) 876.9 (361.2) <.0001 
  Vitamin D (IU) 156.4 (91.6) 201.6 (116.8) 266.0 (144.0) <.0001 
  Protein (gm) 58.3 (12.8) 75.4 (15.3) 98.4 (19.5) <.0001 
  Protein (g/kg) 0.7 (0.1) 1.0 (0.1) 1.42 (0.2) <.0001 
  Protein (wt-adjusted)2 54.0 (8.2) 75.6 (10.7) 101.2 (15.9) <.0001 
  column percent 
Education (% college) 25.0% 26.0% 26.0% 0.9688 
Sex (% male) 44.7% 47.1% 48.6% 0.2569 
Living alone  (%) 12.1% 11.0% 10.6% 0.5875 
Anti-depressant use 4.2% 3.1% 2.6% 0.1739 
1 p-values comparing means (ANOVA) and proportions (Mantel-Haenszel Chi-Square) 
2 Protein intake adjusted for body weight, using residual method 
 
Table 3.2. shows the prevalence of all subjects who were dependent in seven 
functional tasks from the Rosow-Breslau and Nagi Scales. In general, subjects 
with protein intakes below the recommended daily intake (<0.8 gm/kg/day) were 
more likely to have difficulty with a number of functional tasks involving both 
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strength and endurance. By exam 8, the tasks with which these subjects had the 
most difficulty were heavy work around the house, walking ½ mile, and 
stooping, kneeling or crouching. 
 
Table 3.2. Prevalence of dependence functional tasks at exams 5–8 according  
to protein intake  
 Rosow-Breslau Nagi 
Protein Intake Heavy 
Work 
Walk ½ 
Mile Stairs Push/ Pull 
Stoop, 
Kneel 
Lift <10 
lbs 
Lift >10 
lbs 
  Number (%) Number (%) 
  Exam 5 
<0.8 g/kg 52 (13.9%) 16 (4.3%) 17 (4.6%)  19 (5.1%)  39 (10.5%)  3 (0.8%)  17 (4.6%)  
0.8–<1.2 g/kg 75 (7.7%) 22 (2.3%) 16 (1.6%)  38 (3.9%)  50 (5.1%)  4 (0.4%)  28 (2.9%)  
≥ 1.2 g/kg 35 (7.2%) 17 (3.5%) 11 (2.3%)  14 (2.9%)  24 (4.9%)  2 (0.4%)  9 (1.8%)  
p for trend1 0.0010 0.6196 0.0496 0.0925 0.0016 0.4425 0.0209 
  Exam 6 
<0.8 g/kg 25 (7.7%) 18 (5.5%) 12 (3.7%) 13 (4.0%)  32 (9.8%)  3 (0.9%)  13 (4.0%)  
0.8–<1.2 g/kg 68 (7.6%) 31 (3.5%) 13 (1.5%)  34 (3.8%)  51 (5.7%)  6 (0.7%)  32 (3.6%)  
≥ 1.2 g/kg 21 (4.7%) 11 (2.5%) 4 (0.9%)  16 (3.6%)  19 (4.3%)  1 (0.2%)  6 (1.3%)  
p for trend1 0.0805 0.0281 0.0053 0.7705 0.0022 0.2032 0.0252 
  Exam 7 
<0.8 g/kg 30 (9.8%) 23 (7.5%) 6 (2.0%)  15 (4.9%)  34 (11.2%)  5 (1.6%)  14 (4.6%)  
0.8–<1.2 g/kg 79 (9.0%) 37 (4.2%) 6 (0.7%)  33 (3.8%)  55 (6.3%) 5 (0.6%)  29 (3.3%)  
≥ 1.2 g/kg 41 (9.3%) 16 (3.6%) 7 (1.6%)  13 (3.0%)  17 (3.9%)  1 (0.2%)  11 (2.5%)  
p for trend1 0.8606 0.0203 0.8454 0.1720 0.0001 0.0271 0.1247 
  Exam 8 
<0.8 g/kg 53 (21.7%) 54 (22.1%) 25 (10.3%)  20 (8.2%)  53 (21.7%)  11 (4.5%)  23 (9.4%)  
0.8–<1.2 g/kg 132 (18.6%) 94 (13.3%) 42 (5.9%)  49 (6.9%)  86 (12.1%)  15 (2.1%)  40 (5.6%)  
≥ 1.2 g/kg 62 (17.3%) 45 (12.6%) 29 (8.1%)  22 (6.2%)  32 (8.9%)  7 (2.0%)  21 (5.9%)  
p for trend1 0.1899 0.0028 0.4929 0.3392 <.0001 0.0716 0.1186 
  1 p-value is from the Mantel-Haenszel Chi-Square test  
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Table 3.3. shows the proportion of men and women who were unable to do three 
key functional tasks from the Rosow-Breslau Scale according to protein intake 
categories (gm/kg/day). This table shows that women in the higher two (vs. 
lowest) protein intake categories less frequently reported being dependent in 
doing heavy work around the house, walking ½ mile, and going up and down 
stairs. We were unable to detect similar effects in men but the fewer men 
reporting functional task difficulties at each exam cycle led to limited power.  
While the categories in the above tables use protein intake classified as grams per 
kilogram of intake, as used by the Dietary Guidelines, it is possible that these 
effects are confounded by body size. Therefore, Table 3.4 uses a weight-adjusted 
residual method. Subjects were classified into quintiles and then sensitivity 
analyses were used to define low, moderate, and high intakes as the lowest 
quintile vs. quintiles 2–4 and quintile 5. In these analyses, there was some 
attenuation of the effects of high protein intake.  
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Table 3.3. Prevalence of functional dependence among men and women on 
three selected Rosow-Breslau tasks, according to protein intake  
 Men Women 
 Rosow-Breslau Rosow-Breslau 
Protein Intake Heavy 
Work 
Walk 1/2 
Mile 
Stairs Heavy 
Work 
Walk 1/2 
Mile 
Stairs 
  Number (%) Number (%) 
  Exam 5 Exam 5 
<0.8 gm/kg 16 (9.6) 4 (2.4) 4 (2.4)  36 (17.5) 12 (5.8) 13 (6.3)  
0.8–<1.2 gm/kg 29 (6.3) 11 (2.4) 9 (2.0)  46 (9.0) 11 (2.2) 7 (1.4)  
≥ 1.2 gm/kg 10 (4.2) 8 (3.4) 5 (2.1)  25 (9.9) 9 (3.6) 6 (2.4)  
p for trend1 0.0320 0.505 0.8731 0.0163 0.236 0.0170 
  Exam 6 Exam 6 
<0.8 gm/kg 6 (4.1) 5 (3.5) 2 (1.4) 19 (10.4) 13 (7.1) 10 (5.5) 
0.8–<1.2 gm/kg 22 (5.3) 10 (2.4) 4 (1.0)  46 (9.8) 21 (4.5) 9 (1.9)  
≥ 1.2 gm/kg 9 (4.1) 5 (2.3) 1 (0.5)  12 (5.3) 6 (2.6) 3 (1.3)  
p for trend 0.8931 0.522 0.3484 0.0550 0.031 0.0099 
  Exam 7 Exam 7 
<0.8 gm/kg 10 (7.5) 4 (3.0) 1 (0.8)  20 (11.6) 19 (11.1) 5 (2.9) 
0.8–<1.2 gm/kg 29 (7.0) 14 (3.4) 0 (0.00)  50 (10.7) 23 (4.9) 6 (1.3)  
≥ 1.2 gm/kg 12 (5.8) 6 (2.9) 3 (1.4)  29 (12.6) 10 (4.3)  4 (1.7)  
p for trend 0.5031 0.904 0.2275 0.7187 0.008 0.4381 
  Exam 8 Exam 8 
<0.8 gm/kg 19 (19.2) 16 (16.2) 6 (6.1)  34 (23.5) 38 (26.2) 19 (13.1)  
0.8–<1.2 gm/kg 42 (13.3) 34 (10.7) 15 (4.7)  90 (23.0) 60 (15.3) 27 (6.9)  
≥ 1.2 gm/kg 31 (18.9) 22 (13.4) 15 (9.2)  31 (16.0) 23 (11.9) 14 (7.2)  
p for trend 0.7726 0.6950 0.1985 0.0740 0.0007 0.0730 
 1 p-value is from the Mantel-Haenszel Chi-Square test 
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Table 3.4. Prevalence of functional dependence at exams 5–8, according to 
weight-adjusted protein intakes 
 Rosow-Breslau Nagi 
Protein (wt-
adjusted 
residuals) 
Heavy 
Work 
Walk 1/2 
mile 
Stairs Push/Pull Stoop/ 
Crouch 
Lift <10 
lbs 
Lift >10 
lbs 
  Number (%) Number (%) 
  Exam 5  
Low (Q1)  47 (12.7%) 
12  
(3.2%) 
13 (3.5%) 19 (5.1%) 33 (8.9%) 1 (0.3%) 16 (4.3%) 
Mod. (Q2–4) 91 (8.3%) 
29 
(2.6%) 
20 (1.8%) 40 (3.6%) 60 (5.5%) 5 (0.5%) 28 (2.6%) 
High (Q5) 24 (6.6%) 
14  
(3.8%) 
11 (3.0%) 12 (3.3%) 20 (5.5%) 3 (0.8%) 10 (2.7%) 
p-value1 0.0033 0.6468 0.6464 0.1908 0.0505 0.2866 0.1995 
  Exam 6 
Low (Q1)  24 (7.5%) 13 (4.0%) 8 (2.5%) 10 (3.1%) 26 (8.1%) 2 (0.6%) 10 (3.1%) 
Mod. (Q2–4) 75 (7.4%) 40 (4.0%) 19 (1.9%) 45 (4.5%) 58 (5.8%) 7 (0.7%) 37 (3.7%) 
High (Q5) 15 (4.5%) 7 (2.1%) 2 (0.6%) 8 (2.4%) 18 (5.4%) 1 (0.3%) 4 (1.2%) 
p-value 0.1290 0.1779 0.0639 0.6156 0.1551 0.5881 0.1492 
  Exam 7 
Low (Q1)  29 (9.6%) 19 (6.3%) 6 (2.0%) 12 (4.0%) 24 (8.0%) 3 (1.0%) 12 (4.0%) 
Mod. (Q2–4) 92 (9.2%) 46 (4.6%) 8 (0.8%) 40 (4.0%) 69 (6.9%) 6 (0.6%) 33 (3.3%) 
High (Q5) 29 (8.9%) 11 (3.4%) 5 (1.5%) 9 (2.8%) 13 (4.0%) 2 (0.6%) 9 (2.8%) 
p-value 0.7407 0.0816 0.6284 0.4039 0.0402 0.5672 0.3897 
  Exam 8 
Low (Q1)  53 (22.3%) 51 
(21.4%) 
24 (10.1%) 23 (9.7%) 
46 
(19.3%) 
12 
(5.0%) 
22 (9.2%) 
Mod. (Q2–4) 147 
(18.5%) 
107 
(13.5%) 
52 (6.5%) 52 (6.5%) 
97 
(12.2%) 
15 
(1.9%) 
43 (5.4%) 
High (Q5) 47 (16.9%) 35 
(12.6%) 
20 (7.2%) 16 (5.8%) 
28 
(10.1%) 
6 (2.2%) 19 (6.8%) 
p-value 0.1272 0.0065 0.2413 0.0901 0.0024 0.0488 0.3169 
1 P values refer to Mantel-Haenszel Chi-Square test 
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Table 3.5 shows the proportion of subjects’ whose functional status declined by 
Exam 8 among those who were independent at Exam 5. Using both protein 
exposure methods, subjects with the lowest protein intakes had the greatest 
functional decline over the next 3 exam cycles (approximately 12 years). The 
beneficial effects of higher dietary protein intakes were most apparent for two 
functional outcomes - walking ½ mile and stooping/crouching/kneeling. 
Table 3.5. Prevalence of subjects who became dependent in selected tasks over 
12 years, according to dietary protein intake 
 Protein (gm/kg/day) Weight-adjusted Protein1 
Functional 
Status <0.8 0.8–<1.2 ≥ 1.2 
Low 
(Q1) 
Mod.  
(Q2–4) 
High 
(Q5) 
  Number (%) of subjects who became dependent between exams 5 & 82 
Rosow-
Breslau         
Heavy work 51 (18.2) 126 (15.4) 61 (14.9) 52 (18.6) 138 (15.0) 48 (15.4) 
p for trend3  p=0.2775 p=0.3157 
Walk 1/2 mile  56 (18.5) 106 (12.4) 45 (10.6) 54 (18.0) 121 (12.5) 32 (10.1) 
p for trend  p=0.003 p=0.0037 
Stairs 26 (8.6) 42 (4.9) 28 (6.5) 25 (8.3) 53 (5.5) 18 (5.6) 
p for trend  p=0.3815 p=0.1696 
Nagi           
Push/Pull   23 (7.6) 46 (5.4) 23 (5.4) 25 (8.5) 51 (5.3) 16 (5.0) 
p for trend  p=0.2446 p=0.0741 
Stoop/Kneel 42 (14.6) 83 (9.9) 31 (7.5) 37 (12.9) 94 (10.0) 25 (8.0) 
p for trend  p=0.0025 p=0.0488 
Lift <10 lbs. 13 (4.2) 16 (1.8) 8 (1.8) 13 (4.3) 16 (1.6) 8 (2.5) 
p for trend  p=0.0526 p=0.1452 
Lift >10 lbs. 23 (7.7) 45 (5.3) 24 (5.6) 21 (7.1) 53 (5.5) 18 (5.6) 
p for trend  p=0.3010 p=0.4498 
1 Sex-specific quintiles of the weight-adjusted protein residuals 
2 If exam 8 was missing, data from exam 7 was used 
3 p-value from Mantel-Haenszel Chi-Square test 
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To adjust for potential confounding of the above effects, we used Cox 
proportional hazards models to estimate hazard ratios for becoming dependent 
in each of the 7 functional tasks over 12 years.  In these final models, we adjusted 
for the following confounders: age, sex, education, physical activity, cigarettes  
per day, height and total energy intake. In Table 3.6, both of the upper two (vs. 
lowest category) of protein intake had a reduced the risk of becoming dependent 
in most of the selected tasks. Those with the highest protein intakes had the 
lowest risk of becoming dependent over 12 years. 
Table 3.6. Risk of becoming dependent over 12 years in selected functional 
tasks according to three categories of protein intake 
  1 Adjusted for sex, age, education, activity, cigarettes, height, and energy intake 
  Protein Intake (g/kg)  
Functional Task <0.8 gm/kg 0.8-<1.2 gm/kg ≥ 1.2 gm/kg 
  Ref HR1  95% CI HR 95% CI 
Heavy Work at Home 1.00 0.84 (0.62–1.12) 0.68 (0.46–1.01) 
Walk a Half Mile 1.00 0.52 (0.39–0.71) 0.39 (0.26–0.60) 
Flight of Stairs 1.00 0.46 (0.30 –0.71) 0.43 (0.24–0.75) 
Push/Pull Heavy Obj 1.00 0.95 (0.62–1.48) 1.01 (0.57–1.78) 
Stoop, Kneel, Crouch 1.00 0.54 (0.39–0.74) 0.32 (0.20–0.51) 
Lift >10 lbs 1.00 0.74 (0.48–1.15) 0.54 (0.30–0.99) 
Lift <10 lbs 1.00 0.42 (0.21–0.81) 0.18 (0.07–0.51) 
  Weight-Adjusted Protein Residuals2 
Functional Task Low (Q1) Moderate Q(2–4) High Q5 
  Ref HR 95% CI HR 95% CI 
Heavy Work at Home 1.00 0.77 (0.58–1.04) 0.74 (0.49–1.13) 
Walk a Half Mile 1.00 0.60 (0.44–0.82) 0.42 (0.26–0.68) 
Flight of Stairs 1.00 0.69 (0.44–1.09) 0.47 (0.24–0.93) 
Push/Pull Heavy Obj 1.00 0.91 (0.59–1.40) 0.67 (0.35–1.29) 
Stoop, Kneel, Crouch 1.00 0.70 (0.50–0.98) 0.39 (0.23–0.66) 
Lift > 10 lbs 1.00 0.72 (0.46–1.12) 0.55 (0.28–1.07) 
Lift < 10 lbs 1.00 0.37 (0.19–0.74) 0.26 (0.09–0.78) 
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Table 3.7. Relative of becoming dependent over 12 years in 
 selected functional tasks according to protein intake 
  Risk of Becoming Dependent between Exams 5 and 8 
  Protein (g/kg/day) Protein (wt-adj. residual) 
Functional 
Task <0.8 ≥ 0.8 Q1 Q2–Q5 
  Ref HR1  (95% CI) Ref HR1  (95% CI) 
 All Subjects 
Heavy Work 1.00 0.81 (0.61–1.09) 1.00 0.77 (0.58–1.03) 
Walk ½ Mile 1.00 0.50 (0.37–0.68) 1.00 0.59 (0.43–0.80) 
Climb Stairs 1.00 0.46 (0.30–0.69) 1.00 0.68 (0.43–1.06) 
Push/Pull  1.00 0.96 (0.63–1.48) 1.00 0.90 (0.58–1.38) 
Stoop/Crouch 1.00 0.50 (0.36–0.70) 1.00 0.68 (0.48–0.96) 
Lift >10 lbs 1.00 0.71 (0.46–1.10) 1.00 0.71 (0.46–1.11) 
Lift <10 lbs 1.00 0.37 (0.19–0.73) 1.00 0.36 (0.18–0.73) 
Men only 
Heavy Work 1.00 0.82 (0.51–1.31) 1.00 0.87 (0.54–1.37) 
Walk ½ Mile 1.00 0.61 (0.36–1.04) 1.00 0.65 (0.38–1.10) 
Climb Stairs 1.00 0.81 (0.35–1.86) 1.00 1.19 (0.49–2.87) 
Push/Pull  1.00 1.14 (0.36–3.62) 1.00 0.94 (0.32–2.74) 
Stoop/Crouch 1.00 0.60 (0.34–1.06) 1.00 0.90 (0.49–1.63) 
Lift >10 lbs 1.00 0.77 (0.29–2.06) 1.00 0.86 (0.32–2.29) 
Lift <10 lbs 1.00 0.17 (0.03–1.09) 1.00 0.18 (0.03–1.13) 
Women 
Heavy Work 1.00 0.78 (0.53–1.13) 1.00 0.69 (0.47–1.00) 
Walk ½ Mile 1.00 0.46 (0.32–0.67) 1.00 0.56 (0.38–0.82) 
Climb Stairs 1.00 0.37 (0.22–0.61) 1.00 0.54 (0.32–0.92) 
Push/Pull  1.00 0.94 (0.59–1.49) 1.00 0.88 (0.55–1.41) 
Stoop/Crouch 1.00 0.45 (0.30–0.68) 1.00 0.59 (0.39–0.91) 
Lift >10 lbs 1.00 0.71 (0.43–1.16) 1.00 0.68 (0.41–1.12) 
Lift <10 lbs 1.00 0.44 (0.21–0.92) 1.00 0.41 (0.20–0.87) 
1 Adjusted for age, sex (all subjects), education, physical activity, cigarettes per day, height, and energy 
intake 
 
To allow for the examination of the effects of protein intake in men and women 
separately, we then dichotomized protein intake in two ways: (a) ≥ 0.8 vs. <0.8 
g/kg/day and (b) low protein (Q1) vs. higher protein (Q2–Q5).  Table 3.7 
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compares the two protein intake methods and in both, higher protein intakes led 
to a lower risk of developing dependence in the seven functional tasks of interest 
for both men and women. In general, the effects were stronger in women than in 
men. For all subjects, these results demonstrate that dietary protein intakes at or 
above the RDA led to significantly reduced the risk of becoming dependent in 
the ability to walk ½ mile (HR: 0.50, 95% CI: 0.37 – 0.68), go up and down a flight 
of stairs (HR: 0.46, 95% CI: 0.30 – 0.69), stoop/couch/kneel (HR: 0.50, 95% CI: 0.36 
– 0.70), or lift <10 lbs. (HR: 0.37, 95% CI = 0.19 – 0.73).  
For the next analyses (Table 3.8), we estimated the effects of protein intake on the 
risk of becoming dependent in ≥1 and ≥2 functional tasks over 12 years of follow 
up. Both men and women who consumed ≥1.2 g/kg/day of protein were 40–45% 
less likely to become dependent in one or more functional tasks during follow 
up. Overall, those with the highest protein intakes were about 50% less likely to 
become dependent in ≥2 functional tasks over 12 years.  
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Table 3.8. Risk of becoming dependent in multiple functional tasks 
over 12 years according to protein intake  
  
  Risk of becoming dependent between exams 5 and 8 
  Protein Intake (g/kg/day) 
Subjects <0.8  0.8–<1.2  ≥1.2  
  Ref HR1  (95% CI) HR1 (95% CI) 
  Dependent in ≥1 Task 
All Subjects 1.00 0.82 (0.64 – 1.04) 0.59 (0.43 – 0.82) 
Men 1.00 0.71 (0.49 – 1.05) 0.60 (0.36 – 1.00) 
Women 1.00 0.86 (0.62 – 1.18) 0.55 (0.36 – 0.86) 
  Dependent in ≥2 Tasks 
All Subjects 1.00 0.67 (0.49 – 0.90) 0.49 (0.33 – 0.74) 
Men 1.00 0.74 (0.42 – 1.30) 0.90 (0.45 – 1.82) 
Women 1.00 0.64 (0.45 – 0.92) 0.35 (0.21 – 0.59) 
                    
  Protein Intake (Weight-adjusted Residuals) 
  Quintile 1 Quintiles 2–4 Quintile 5 
 Ref HR1*  (95% CI) HR1 (95% CI) 
  Dependent in ≥1 Task 
All Subjects 1.00 0.79 (0.62 – 1.01) 0.61 (0.42 – 0.86) 
Men 1.00 0.88 (0.60 – 1.29) 0.70 (0.39 – 1.25) 
Women 1.00 0.71 (0.52 – 0.98) 0.53 (0.33 – 0.84) 
  Dependent in ≥2 Tasks 
All Subjects 1.00 0.79 (0.58 – 1.07) 0.51 (0.32 – 0.81) 
Men 1.00 0.81 (0.47 – 1.39) 0.65 (0.29 – 1.48) 
Women 1.00 0.78 (0.53 – 1.13) 0.44 (0.24 – 0.79) 
1 Adjusted for age, sex (all subjects), education, physical activity, cigarettes per day, height, 
and energy intake 
 
The next analytic objective was to evaluate whether physical activity, body mass 
index, or the amount of skeletal muscle mass modified the effect of dietary 
protein on functional decline. Table 3.9 explores effect modification by physical 
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activity. We hypothesized that subjects who were more active and consumed 
more protein would have a lower risk of functional decline and our results 
confirmed that hypothesis. Subjects with higher physical activity levels and 
higher weight-adjusted protein intakes were 50% less likely (95% CI: 0.34 – 0.74) 
to become dependent in one or more functional tasks over follow up. Results 
were similar in men (HR 0.56, 95% CI 0.29–1.08) and women (HR 0.47, 95% CI 
0.29–0.77). Finally, higher protein intake and physical activity levels led to almost 
a 60% reduction in risk of becoming dependent in two or more tasks over 12 
years.   
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Table 3.9. Effect modification of dietary protein by physical activity level on 
risk of functional dependence over 12 years 
 
 Risk of Becoming Dependent in ≥1 Tasks 
Combined Effects All Subjects Men only Women only 
  HR1 95% CI  HR 95% CI  HR 95% CI  
Activity Level / Prot. Intake   
 
  
 
  
 
Low p.a.2, Low Wt-adj Prot.3 Ref 
 
  
 
  
 
Low p.a., High Wt-adj Prot.3  0.67 (0.47–0.95) 0.83 (0.46–1.48) 0.57 (0.37–0.88) 
High p.a.2, Low Wt-adj Prot.  0.58 (0.37–0.90) 0.64 (0.31–1.32) 0.56 (0.32–1.00) 
High p.a., High Wt-adj Prot.  0.50 (0.34–0.74) 0.56 (0.29–1.08) 0.47 (0.29–0.77) 
              
Low p.a., Prot. <0.8 g/kg Ref           
Low p.a., Prot. ≥0.8 g/kg 0.70 (0.50–0.99) 0.61 (0.36–1.03) 0.76 (0.48–1.20) 
High p.a., Prot. <0.8 g/kg 0.61 (0.39–0.95) 0.55 (0.28–1.10) 0.68 (0.38–1.23) 
High p.a., Prot. ≥0.8 g/kg 0.52 (0.35–0.76) 0.43 (0.24–0.78) 0.59 (0.35–0.99) 
  Risk of Becoming Dependent in ≥2 Tasks 
  All Subjects Men only Women only 
  HR 95% CI  HR 95% CI  HR 95% CI  
Low p.a., Low Wt-adj Prot. Ref 
 
  
 
  
 
Low p.a., High Wt-adj Prot.  0.54 (0.36–0.82) 0.59 (0.28–1.23) 0.51 (0.31–0.85) 
High p.a., Low Wt-adj Prot.  0.40 (0.23–0.71) 0.43 (0.16–1.15) 0.39 (0.19–0.79) 
High p.a., High Wt-adj Prot.  0.42 (0.26–0.68) 0.43 (0.18–1.01) 0.42 (0.24–0.75) 
    
 
  
 
  
 
Low p.a., Prot. <0.8 g/kg Ref 
 
  
 
  
 
Low p.a., Prot. ≥0.8 g/kg 0.43 (0.29–0.64) 0.50 (0.25–1.00) 0.39 (0.24–0.64) 
High p.a., Prot. <0.8 g/kg 0.38 (0.22–0.66) 0.32 (0.11–0.91) 0.39 (0.20–0.76) 
High p.a., Prot. ≥0.8 g/kg 0.35 (0.22–0.55) 0.39 (0.17–0.89) 0.33 (0.19–0.59) 
1 Adjusted for age, sex (all subjects), education, cigarettes per day, height and energy intake 
2 Low physical activity (p.a.) = Q1–Q2 vs./ Q3–Q5 (using sex-specific quintiles) 
3 Low vs. high protein: Q1 vs. Q2–Q5 (residual method) 
 
Table 3.10 explores potential effect modification by BMI while Table 3.11 
examines effect modification by %SMM. In majority of these analyses, but 
particularly for women, a BMI <28 combined with higher protein intake led to a 
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reduced risk of becoming dependent in both ≥ 1 and ≥2 functional tasks over 12 
years of follow up.  
Table 3.10. Effect modification of dietary protein by physical activity level on 
risk of functional dependence over 12 years 
 
Risk of Becoming Dependent in ≥1 Tasks 
Combined Effects All Subjects Men only Women only 
  HR1 95% CI  HR 95% CI  HR 95% CI  
BMI / Protein Intake   
 
  
 
  
 BMI≥28, Low  Wt-adj Prot.2  Ref 
 
  
 
  
 BMI≥28, High  Wt-adj Prot.2 0.99 (0.72–1.36) 1.08 (0.68–1.72) 0.91 (0.58–1.41) 
BMI<28, Low  Wt-adj Prot. 0.67 (0.44–1.01) 0.64 (0.31–1.33) 0.66 (0.40–1.11) 
BMI<28, High  Wt-adj Prot.  0.56 (0.42–0.76) 0.63 (0.41–0.99) 0.49 (0.33–0.74) 
  
BMI≥28, Protein <0.8 g/kg Ref           
BMI≥28, Protein ≥0.8 g/kg 0.87 (0.64–1.19) 0.82 (0.53–1.29) 0.91 (0.59–1.39) 
BMI<28, Protein <0.8 g/kg 0.43 (0.27–0.70) 0.45 (0.18–1.16) 0.44 (0.25–0.77) 
BMI<28, Protein ≥0.8 g/kg 0.54 (0.41–0.71) 0.53 (0.35–0.81) 0.53 (0.37–0.77) 
  Risk of Becoming Dependent in ≥2 Tasks 
  All Subjects Men only Women only 
  HR 95% CI  HR 95% CI  HR 95% CI  
BMI≥28, Low  Wt-adj Prot. Ref 
 
  
 
  
 BMI≥28, High  Wt-adj Prot.  0.89 (0.59–1.34) 0.75 (0.37–1.53) 1.06 (0.63–1.77) 
BMI<28, Low  Wt-adj Prot.  0.70 (0.41–1.17) 1.14 (0.43–3.01) 0.61 (0.32–1.13) 
BMI<28, High  Wt-adj Prot. 0.60 (0.42–0.87) 0.87 (0.46–1.64) 0.50 (0.31–0.79) 
  
      BMI≥28, Protein <0.8 g/kg Ref 
 
  
 
  
 BMI≥28, Protein ≥0.8 g/kg 0.62 (0.41–0.92) 0.62 (0.31–1.24) 0.69 (0.42–1.14) 
BMI<28, Protein <0.8 g/kg 0.50 (0.28–0.90) 0.85 (0.25–2.95) 0.42 (0.22–0.81) 
BMI<28, Protein ≥0.8 g/kg 0.50 (0.36–0.70) 0.79 (0.44–1.44) 0.40 (0.27–0.61) 
 
1 Adjusted for education, physical activity, cigarettes per day, height, and energy 
2 Low vs. high protein: Q1 vs. Q2–Q5 (residual method) 
In Table 3.11, we were not able to estimate the effects of dietary protein and 
%SMM on two or more functional disabilities, particularly in men, because there 
83 
 
were too few men in some categories. For example, few men who consumed <0.8 
g/kg of protein had higher levels of lean body mass, yielding low power to 
estimate these effects. Table 3.11 suggests that there is additive interaction 
between dietary protein intake and %SMM.  
3.11. Potential modification of protein effects on risk of becoming dependent 
in ≥ 1 functional tasks over 12 years by Skeletal Muscle Mass (SMM) 
 
 Risk of Becoming Dependent in ≥1 Tasks 
Combined Effects All Subjects Men only Women only 
  HR1 95% CI  HR 95% CI  HR 95% CI  
%SMM / Protein Intake   
 
  
 
  
 
Low SMM2, Low Wt-adj Prot.3 Ref 
 
Ref 
 
Ref 
 
Low SMM, High Wt-adj Prot.3 0.93 0.67–1.30 1.21 0.68–2.18 0.76 0.51–1.15 
High SMM2, Low Wt-adj Prot. 0.71 0.46–1.10 1.06 0.50–2.27 0.57 0.33–0.97 
High SMM, High Wt-adj Prot.  0.55 0.39–0.76 0.75 0.41–1.37 0.43 0.29–0.64 
  HR 95% CI  HR 95% CI  HR 95% CI  
Low SMM, Protein <0.8 g/kg Ref   Ref   Ref   
Low SMM, Protein ≥0.8 g/kg 0.98 0.70–1.36 1.26 0.69–2.28 0.83 0.56–1.24 
High SMM, Protein <0.8 g/kg 0.57 0.36–0.92 1.21 0.55–2.67 0.39 0.21–0.72 
High SMM, Protein ≥0.8 g/kg 0.60 0.43–0.82 0.77 0.42–1.41 0.50 0.34–0.73 
  Risk of Becoming Dependent in ≥2 Tasks 
  All Subjects Men only Women only 
  HR 95% CI  HR 95% CI  HR 95% CI  
Low SMM, Low Wt-adj Prot. Ref 
 
Ref 
 
Ref 
 
Low SMM, High Wt-adj Prot. 0.78 0.52–1.18 1.24 0.48–3.21 0.73 0.46–1.16 
High SMM, Low Wt-adj Prot. 0.57 0.31–1.03 1.92 0.60–6.11 0.38 0.18–0.78 
High SMM, High Wt-adj Prot. 0.55 0.37–0.84 1.56 0.61–3.99 0.38 0.24–0.61 
  HR 95% CI  HR 95% CI  HR 95% CI  
Low SMM, Protein <0.8 g/kg Ref 
 
Ref 
 
Ref 
 
Low SMM, Protein ≥0.8 g/kg 0.63 0.42–0.93 1.51 0.54–4.16 0.55 0.35–0.86 
High SMM, Protein <0.8 g/kg 0.37 0.19–0.73 1.70 0.44–6.51 0.24 0.11–0.55 
High SMM, Protein ≥0.8 g/kg 0.49 0.33–0.72 1.92 0.71–5.22 0.33 0.21–0.51 
 
1	Adjusted for sex (all subjects), age, education, activity, cigarettes, height, and energy intake 
2 Low %SMM = <36 for men and <26 for women; high %SMM = ≥36% for men and ≥26% for women 
3 Low vs. high protein: lowest sex-specific quintile vs. upper four sex-specific quintiles 
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Figures 3.1, 3.2, and 3.3 show the effect of average protein intake during the 
baseline period on a weighted composite score of functional status, calculated 
prospectively at exams 5 through 8. Higher scores here reflect higher levels of 
physical functioning. In these analyses, we found that protein intakes of ≥RDA 
(vs. <RDA) were associated with the lowest levels of functional decline 
throughout follow up period. These effects once again seemed to be much 
stronger in women than in men. 
Figure 3.1. Functional status score, exams 5 to 8, according to protein intake 
(below RDA vs. ≥ RDA) 
Adjusted for sex, age, education, activity, cigarettes/day, height, and energy intake 
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Figure 3.2. Functional status score, exams 5 to 8, according to protein intake – 
men only 
 
Figure 3.3. Functional status score, exams 5 to 8, according to protein intake – 
women only 
 
Adjusted for age, education, activity, cigarettes/day, height, and energy intake 
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To evaluate whether higher intakes of dietary protein have a greater beneficial 
effect on physical functioning, Figures 3.4, 3.5, and 3.6 explore 3 categories of 
intake (<0.8, 0.8–<1.2, and ≥1.2 g/kg/day). In these analyses, there was a tendency 
for women consuming 1.2 g/kg/day or more to have higher physical functioning 
scores throughout the follow up period than those with lower or intermediate 
levels of intake.  
Figure 3.4. Functional status score, exams 5 to 8, according to protein intake in 
three categories of intake (grams per kilogram per day) 
 
 
Adjusted for sex, age, education, activity, cigarettes/day, height, and energy intake 
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Figure 3.5 Functional status score, exams 5 to 8, according to protein intake in 
three categories (grams per kilogram per day) – men only 
 
 
 
 
Figure 3.6 Functional status score, exams 5 to 8, according to protein intake in 
three categories (grams per kilogram per day) – women only 
 
 
Adjusted for age, education, activity, cigarettes/day, height, and energy intake 
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Figures 3.7, 3.8, and 3.9 repeat the same analyses shown above but using 
quintiles of weight-adjusted protein residuals as the exposure. There was no 
meaningful difference between these results and those using the gm/kg protein 
intake variable except perhaps among men.  
Figure 3.7. Functional status score, exams 5 to 8, according to protein intake in 
three categories of intake (based on quintiles of weight-adjusted protein 
residuals) 
 
 
Adjusted for sex, age, education, activity, cigarettes/day, height, and energy intake 
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Figure 3.8 Functional status score, exams 5 to 8, according to protein intake in 
three categories (weight-adjusted protein residuals) – men only 
 
 
 
Figure 3.9 Functional status score, exams 5 to 8, according to protein intake in 
three categories (weight-adjusted protein residuals) – women only 
 
 
 
Adjusted for age, education, activity, cigarettes/day, height, and energy intake 
90 
 
The goal of the analyses shown in Figures 3.10, 3.11, and 3.12 is to explore 
possible effect modification between protein intake and physical activity on 
functional performance scores measured repeatedly from exams 5 to 8 adjusting 
for sex (for all subjects), age, education, physical activity and cigarettes per day, 
height, and energy intake. These figures shows that subjects with low protein 
and low activity levels have the greatest decline functional status over time. 
These results confirm previous analyses showing that women experience greater 
declines in functional capacity over time than men.  
 
Figure 3.10. Functional status score, exams 5–8, according to combined 
categories of dietary protein and physical activity 
 
Low vs. high activity based on quintiles: (Q1–Q2 vs. Q3–Q5)  
Low vs. high protein: Sex-specific Q1 vs. Q2–Q5 
Adjusted for sex, age, education, physical activity, cigarettes/day, height, and energy intake 
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Figure 3.11. Functional status score, exams 5–8, according to combined 
categories of dietary protein and physical activity – men only 
 
 
 
Figure 3.12. Functional status score, exams 5–8, according to combined 
categories of dietary protein and physical activity – women only 
 
Low vs. high activity based on quintiles: (Q1–Q2 vs. Q3–Q5)  
Low vs. high protein: Sex-specific Q1 vs. Q2–Q5 
Adjusted for age, education, physical activity, cigarettes/day, height, and energy intake 
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Fig 3.13, 3.14, and 3.15 similarly show effect modification between protein intake 
and %SMM, using repeated-measures mixed longitudinal regression models. 
Overall, subjects with low protein intakes and low SMM had greater declines in 
the functional status score than those in other groups. These effects were not 
apparent in men, for whom low levels of SMM, regardless of protein intake, were 
associated with higher levels of functional decline over time. Among women, 
there was evidence of interaction between protein intake and %SMM with 
respect to these functional outcomes.  
Figure 3.13. Functional status score, exams 5–8, according to combined 
categories of dietary protein and percent skeletal muscle mass 
 
Low vs. high %SMM: <35% vs. ≥36% in men; <26% vs.  ≥26% in women 
Low vs. high protein: sex-specific Q1 vs. Q2–Q5 
Adjusted for age, sex, education, physical activity, cigarettes/day, height, and energy intake 
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Figure 3.14 Functional status score, exams 5–8, according to combined 
categories of dietary protein and percent skeletal muscle mass – men only 
 
 
 
Figure 3.15 Functional status score, exams 5–8, according to combined 
categories of dietary protein and percent skeletal muscle mass – women only 
 
 
Low vs. high %SMM: <35% vs. ≥36% in men; <26% vs.  ≥26% in women 
Low vs. high protein: Sex-specific Q1 vs. Q2–Q5 
Adjusted for age, education, physical activity, cigarettes/day, height, and energy intake  
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3.4. Discussion 
We examined the effects of protein intake on selected functional tasks measures 
among 1894 community-dwelling adults (men 892, women 1009) ages 50 years 
and older who were followed for 12 years in the FOS. Protein intakes were 
measured in two ways: grams per kilogram of body weight and weight-adjusted 
sex-specific protein intake calculated using residuals from a linear regression 
model. We selected seven specific functional tasks from the Rosow-Breslau and 
Nagi Scales that related most directly to strength and endurance requirements.  
In this study we found that protein intake at or above the RDA (vs. below the 
RDA) led to a lower risk of becoming dependent in nearly all of the seven 
selected functional tasks (heavy work at home, walking ½ mile, going up and 
down a flight of stairs, pushing and pulling heavy objects, stooping/ kneeling/ 
crouching, lifting<10 lbs and lifting >10 lbs). The estimated effects were stronger 
among women than men. Our findings also indicated that those in the highest 
protein intake category (≥ 1.2 g/kg or highest quintile of the weight-adjusted 
residuals) had even stronger protection from functional decline.   
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We also explored composite risk scores in these analyses and found that subjects 
with the lowest protein intakes had the lowest functional status scores over 12 
years of follow up and, once again, these effects were stronger in women than in 
men. In this study, men reported fewer functional difficulties than did women 
and as a result, the smaller number of men who became dependent compared 
with women may have yielded lower statistical power to identify any association 
between protein intake and functional decline among men.  
Finally, we also observed that higher protein intake when combined with higher 
physical activity levels led to much lower risks of becoming dependent in one or 
more functional tasks over time. The beneficial effects of physical activity on 
functional status (alone or in combination with higher intakes of dietary protein) 
were evident in both men and women although the effects were consistently 
stronger in women. We also examined effect modification of protein by BMI and 
by percent skeletal muscle mass on functional outcomes. Here, we found that 
higher protein intakes had the greatest benefits among non-obese individuals. 
Our longitudinal analyses further support the presence of effect modification of 
protein intake by physical activity, BMI and SMM on functional status scores 
over 12 years. 
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It is increasingly recognized that short-term nitrogen balance studies provide 
only limited information on dietary protein requirements for older adults. A 
more effective approach would be to determine the level of dietary protein that is 
needed to provide direct benefits to health outcomes (172). Emerging data 
indicate that optimal health in older people depends on maintaining muscle 
mass, which may require more than the current amounts of dietary protein 
recommended by the Dietary Guidelines (172, 173). Fukagawa and other 
researchers have proposed that the adequacy of protein intake should be based 
on clinically meaningful functional outcomes (172, 174, 175). That is, the optimal 
level of dietary protein intake should be determined based on its effects on 
physical functioning capacities in middle-aged and older adults. Some prior 
studies have also found that higher dietary protein intake is needed for older 
adults to remain functionally active (91, 176–180). However, few studies have 
examined this issue directly. 
A number of studies have suggested that older adults need higher amounts of 
dietary protein than younger adults to maintain lean body mass. This age-related 
need for increased dietary protein is thought to relate to several factors including 
a declining anabolic response to protein intake in older adults as well as a need 
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for more protein to offset inflammatory and catabolic conditions associated with 
chronic and acute diseases that occur commonly with aging. In addition, older 
adults often consume less protein than do younger adults (181–183).  
Loss of muscle strength, often a surrogate marker for physical functioning, is 
associated with reduced functional capacity, decreased amount of skeletal 
muscle, impaired muscle quality, neurological dysfunction, and other comorbid 
conditions (184). In the Aging and Body Composition (Health ABC) study of 
2066 older men and women aged 70–79 y, those in the highest quintile of protein 
intake (1.2 gm/kg) lost approximately 40% less total and appendicular lean mass 
than those in the lowest quintile (0.8 gm/kg) after 3 years of follow-up (32). One 
clinical trial found that the current RDA for older adults was not adequate to 
prevent loss of mid-thigh muscle area over a 14-week period in healthy older 
adults (38). But one study conducted by Gregorio et al. found that women whose 
intakes were at or above the RDA for protein intake (vs. less) had better upper 
and lower extremity strength (185). These results are consistent with our own 
findings in women. 
Health and functioning of older adults are influenced by a number of factors, 
including physical activity, weight status, and amount of lean body mass. In our 
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study with over 12 years of follow up, we also found that subjects who were non-
obese, more active, and/or who had more SMM maintained more functional 
status over time. In the longitudinal InCHIANTI Study among community-
dwelling adults aged ≥ 65 years, obese subjects (≥ 30 vs. <30 kg/m2) with lower 
(vs. higher) muscle strength were more likely to experience walking speed 
decline and to develop new mobility disabilities over 6 years of follow-up (186). 
The rate of obesity in the older populations is rising and this may be both a cause 
and a consequence of decreased physical activity and other age-related hormonal 
changes (187). The current study demonstrates that taken together low levels of 
physical activity, declining strength, and increasing levels of obesity are likely to 
put our aging population at ever-increasing risk of functional dependence in old 
age. Some prior studies have shown that adequate protein intake combined with 
strength training can result in substantial improvements in muscle mass, 
strength, and physical performance in older adults (162, 188–191).  
There are several important strengths of this study. One is the length of follow-
up, which averaged 12 years from baseline protein intake to final measurement 
of functional status. In addition, baseline protein intake was derived from 
detailed 3-day dietary records. Physical functioning outcomes were measured by 
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well-validated Rosow-Breslau and Nagi Scales at four sequential exams. Finally, 
we used two different methods for expressing protein intake to account for 
possible confounding by the subject’s body size: grams/kilogram of intake and 
weight-adjusted sex-specific protein residuals. The similarity in the results of 
these two different approaches provides greater confidence in the finding of a 
beneficial effect of higher protein intake. 
One limitation of this study is the lack of performance-based measures of 
functional status. It would be helpful to include such measures in future studies. 
The limited number of functional dependencies among men in this study (due to 
the age of the population) is another limitation. Thus, it will be important to 
replicate these analyses in the future by adding data from later exam cycles in 
Framingham to enhance the power of these analyses.  
Conclusion  
The results from this study suggest that middle-aged and older community-
dwelling adults with low dietary protein intakes, particularly those whose intake 
is below the current RDA, are at greater risk for developing functional decline 
over the next decade. This study also supports the premise that even higher 
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protein intakes (e.g., ≥ 1.2 gm/kg) may be of additional benefit in terms of 
protection from functional decline. We found that obese individuals, particularly 
those with lower protein intakes, had a greater chance of become dependent over 
time. Finally, this study also supports the importance of physical activity in the 
prevention of age-related functional dependence. These results add to the 
existing evidence that higher intakes of protein, regular physical activity, and 
maintaining optimal weight are protective against age-related functional decline. 
Future studies with greater statistical power are needed to evaluate the 
appropriate threshold for dietary protein intake that will optimize functional 
status and quality of life in older adults. 
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CHAPTER FOUR: THE EFFECTS OF CALCIUM AND VITAMIN D ON 
PHYSICAL FUNCTIONING OUTCOMES AMONG THE FRAMINGHAM 
OFFSPRING SUBJECTS (FOS) 
4.1. Background 
As the aging population increases rapidly, there is a growing emphasis on the 
importance of preserving physical capacities and functional independence 
among older adults (192). Aging is associated with progressive decline in 
physical functioning that can lead to the risk of falling, fracture, frailty, disability 
and poor quality of life (193, 194). Both vitamin D and calcium have been linked 
with musculoskeletal health and may thereby play important roles in the 
preservation of physical functioning during the ageing process.  
Circulating calcium ions regulate a number of processes including muscle 
contraction and relaxation; thus, normal serum calcium levels are vital for muscle 
function and physical performance (195). Likewise, vitamin D receptors are 
present in all tissues including skeletal muscle; therefore, vitamin D is also 
implicated in muscle movement, strength, and physical performance (39, 40. 
Over the last couple of decades, we have learned that vitamin D status 
[(25(OH)D] may be linked with calcium homeostasis, musculoskeletal health, 
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cardiovascular health, diabetes mellitus, hypertension, and osteoarthritis (41). 
Therefore, low vitamin D status in middle-aged and older adults may lead to 
poorer physical functioning through its effects on muscle, bone health, and 
associated co-morbidities (42). Elderly populations are the most vulnerable 
group for vitamin D deficiency due to reduced capacity for vitamin D synthesis 
in the skin, limited exposure to the sun, lower food intakes, reduced intestinal 
absorption, and less renal production of cholecalciferol (45–48). In particular, 
there is a decrease in cutaneous levels of 7-dehydrocholesterol associated with 
aging thus reducing the capacity to produce vitamin D3 in skin (45). According 
to data from the 2000–2004 National Health and Nutrition Examination Survey 
(NHANES), about one-third of the older adults (age 70 and above) were vitamin 
D deficient (25(OH)D < 20 ng/mL) and 75% were vitamin D insufficient 
(25(OH)D < 30 ng/mL) (49). One study found that 80–100% of elderly home care 
residents living in Europe, Australia and North America were vitamin D 
deficient (50). The biological activity of vitamin D is mediated by 1,25(OH)D. It 
acts on the high-affinity receptor vitamin D receptor (VDR), which is distributed 
throughout the body including bone and muscle cells (41). 
This membrane-bound VDR mediates the action of 1,25(OH)D on calcium influx 
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and muscle contractility (52). 1,25(OH)D acts on VDR, which activates gene 
transcription resulting in the synthesis of specific proteins and regulation of bone 
and muscle cell differentiation and proliferation (53, 196). 
Prior studies including cross-sectional, prospective studies and clinical trial 
studies have found beneficial effects of vitamin D and calcium intake on health 
and well-being. In a cross-sectional study of community-dwelling adults aged ≥ 
60 years, 25(OH)D concentrations between 40 and 94 nmol/L (vs. < 40 nmol/L) 
were associated with better lower extremity functional performance on a walk 
test (timed 8-foot) and a repeated sit-to-stand test (58). In a 3-year prospective 
study of 1234 men and women (aged ≥65 years), subjects with serum 25-OHD 
levels above 30 ng/ml (vs. <10 ng/ml) had significantly better physical 
performance (on walking tests, chair stands, and tandem stand) (59). In another 
prospective study of community-dwelling subjects (192 women and 188 men, 
aged 70 years and above) with higher vitamin D status and calcium intake levels 
above ≥ 512 mg/day (vs. low vitamin D status and low calcium intake) had 
significantly better functional mobility outcomes (faster average “timed-up and 
go” test (TUG-test)) (197).  
A study of 64 institutionalized elderly women (ages: 65–97 years) found that 
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those receiving calcium plus vitamin D supplementation (1,200 mg calcium plus 
800 IU cholecalciferol) compared with calcium supplementation alone had a 60% 
lower risk of falls as a result of improved balance (198). Similarly, in a clinical 
trial of 242 community dwelling subjects (mean age 77 years), the intervention 
group receiving 1000 mg of calcium plus 800 IU of vitamin D (vs. calcium alone) 
had statistically significantly lower risks of falling and improved muscle function 
(as measured by quadriceps strength, body sway, time needed to perform the 
TUG test) over 12 months of follow-up (66). However, not all studies found a 
positive association between vitamin D and calcium intakes and physical 
functioning. For example, the Women’s Health Initiative double-blind, placebo-
controlled clinical trial study of 33,067 women, aged 50 to 79 years at 40 US study 
centers, were provided 1,000 mg calcium carbonate plus 400 IU of vitamin D3 
(vs. placebo). After 7.1 years of follow up, there was no impact on change in 
physical functioning over time (67).  
The addition of resistance training to vitamin D and/or calcium supplementation 
is also thought to benefit functional performance. However, one study of frail 
older adults who were discharged from the hospital with vitamin D 
supplementation (300,000 IU of calciferol vs. placebo) and 10 weeks of high-
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intensity home-based quadriceps resistance exercise, found no improvements in 
balance or physical performance (199). In contrast, elderly Chilean vitamin D 
deficient (16 ng/ml or less) subjects (aged 70 years or more), who took vitamin D 
and calcium supplements (vitamin D 400 IU plus 800 mg of calcium per day) and 
who underwent resistance training had statistically significant improvements in 
several physical performance tests (quadriceps muscle strength, short physical 
performance battery, TUG speed, and gait speed) (200).  
With relatively short follow-up periods, most of the studies to date were unable 
to assess long term effects of vitamin D and calcium on physical functioning. 
Therefore, data from the Framingham Offspring Study with follow up for 12 
years provide a valuable opportunity to examine the long-term effects of usual 
vitamin D and calcium intake on functional outcomes over time.  
4.2. Study design 
Study population  
The Framingham Heart Study started in 1948 with 5,209 male and female 
subjects randomly recruited from the town of Framingham, MA. A second- 
generation study, the Framingham Offspring Study (FOS), was begun in 1971 
106 
 
with the recruitment of the original participants’ adult children and their spouses 
(n = 5,124). After a second examination visit in 1980 eight years after enrollment, 
FOS subjects were examined every four years at the Framingham Heart Study 
Clinic in Framingham.  
For our analyses, we included 1894 subjects (men=891, women=1003) who met 
the following eligibility criteria: 1.) at least 50 years old at exam 3, 4, or 5 
(baseline for these analyses), and 2.) responded to all of the following seven 
selected functional task questions derived from the Rosow-Breslau and Nagi 
scales: heavy work around the house; walking up and down stairs; walking half 
a mile; pulling or pushing large objects; stooping, crouching, or kneeling; lifting 
or carrying weights under 10 pounds; lifting or carrying weights over 10 pounds.  
Subjects were excluded from these analyses if they met any of the following 
criteria: (1) did not attend exams 3, 4 or 5 (n= 740); (2) provided no food diary 
data (n = 1100); (3) reported extreme energy intakes (for men, < 1200 calories or > 
4000 calories per day; for women, < 1000 calories or > 3500 calories per day) (n = 
322); (4) were less than 50 years old at exams 3, 4, and 5 (n = 868); (5) did not 
attend exams 5, 6, 7 and 8 when functional status data were collected (n = 119); 
(6) had a diagnosis of prevalent cancer (except non-melanoma skin cancer) at 
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time of baseline functional assessment (n =71); or (7) had incomplete or missing 
functional variables (i.e., the 7 selected tasks derived from Rosow-Breslau and 
Nagi Scales) at exams 5, 6, 7 and 8 (n = 10). Based on these inclusion and 
exclusion criteria, a total of 3230 subjects from the Framingham Offspring Study 
were excluded from the total 5,124 FOS subjects, leaving a subset of 1894 subjects 
for our analyses. This number included 891 men and 1003 women. 
Dietary assessment  
FOS subjects’ dietary data were recorded using 3-day diet records following 
standardized procedures and supervised by a trained nutritionist in exam 3 cycle 
(1984–1988) and 5 cycle (1991–1995). Subjects completed the 3-day diet record 
using 2 dimensional food models to aid in the estimation of dietary portion sizes. 
To derive the daily intake of nutrients including vitamin D and calcium, each 
subject’s 3-day dietary records were analyzed using the Nutrition Data System 
(NDS), a nutrient calculation program developed by University of Minnesota 
(167). Subjects’ vitamin D and calcium were measured in mcg per day (then 
converted to IU by multiplying by 40) and mg per day intakes respectively.  
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Functional status outcome assessment  
Data on the functional status of FOS subjects were collected routinely at every 
exam cycle. Two well-validated scales were employed for this purpose: 1) Nagi 
scale (168) (a self-reported functional status scale consisting of 11 items scored on 
a 0–5 range); 2) Rosow-Breslau scale (169) (a self-reported scale to measure the 
functional status on gross-mobility tasks with 6 items questionnaire on a 0–1 
range).  
For this study, we selected seven specific tasks measured by the Rosow-Breslau 
and Nagi scales at exams 5 through 8. Specifically, these seven tasks were ones 
that were particularly related to the strength and endurance that underlie the 
functional status. The three tasks selected from the Rosow-Breslau Scale included 
heavy work at home (like shoveling, washing windows, walls or floors), walking 
1/2 mile (about 4–6 blocks), and going up and down a flight of stairs. Subjects 
were asked to report their ability to do these tasks independently; those using a 
cane or other assistive device were considered independent as long as they did 
not require assistance from another person. The four tasks selected from the Nagi 
Scale included pushing/pulling heavy objects (like a living room chair), stooping, 
kneeling, and crouching, lifting <10 pounds (like a bag of potatoes) and lifting>10 
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lbs (a very heavy bag of groceries). Subjects’ responses on these 4 functional tasks 
were scored as 0=no difficulty, 1=a little difficulty, 2=some difficulty, 3=a lot of 
difficulty, 4=unable to do). These responses were further collapsed to a 
dichotomous outcome as follows: able to do (categories 0, 1, or 2) vs. unable to do 
(categories 3 and 4). 
Assessment of potential confounders 
Subjects’ baseline age, sex, and education were included as potential 
confounders. Education level was categorized as college graduate or less 
education. Subject’s weight and height were measured to the nearest 0.25 pound 
and to the nearest 0.25 inch, respectively, using a standard counterbalance scale 
with a measuring bar.  
Body mass index (BMI) 
We used the individual’s weight at baseline and the average adult height (ages 
18–60 for women and ages 21–60 for men) to calculate exam-specific BMIs as 
weight in kg divided by height in meter squared. The use of mean height will 
help to reduce measurement errors and the effect of height loss after age 60.  
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Cigarette smoking and alcohol 
Cigarette smoking information was collected routinely at every FHS examination 
to assess subjects’ current and past smoking status as well as total pack-years. 
Subjects who smoked at least one cigarette per day were considered as current 
smoker. In our study, subjects’ smoking status was reported as number of 
cigarette smoked per day.  
Subjects’ alcohol intake information was collected based on self-reported alcohol 
intake. Subjects’ alcohol intake status was collected routinely at each FHS exam 
as drinking status (e.g., current or past drinker, abstainer, abuser), drinking 
frequency (lifetime abstainer, past drinker, occasional drinker, regular drinker), 
and drinking amount (light, moderate, heavy). In our study, subjects’ drinking 
status were reported as gm of alcohol per day intake.  
Physical activity index 
Physical activity was assessed by self-report at exams 2 and 4. A history of usual 
activity was recorded from each subject’s number of hours a day spent in sleep, 
sedentary activities, physical activity (light, moderate, and vigorous) in a 24 hour 
period. A composite score, the physical activity index, was derived by summing 
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up the products of the hours at each level of activity (which includes moderate 
and vigorous activities) times a weight based on the estimated energy 
expenditure (oxygen consumption) required for that activity. For moderate level 
of activity, we multiplied by the 2.4 weight factor and for heavy level of activity, 
we multiplied by the 5 weight factor in order to derive the final physical activity 
index (170). We used the average physical activity index from exams 2 and 4 as 
an indicator of usual baseline activity.  
Skeletal Muscle Mass 
Each subjects’ skeletal muscle mass (SMM) was determined using the Janssen et 
al equation (171) as follows:  
SMM (kg) = [(Height2 / BIA-resistance x 0.401) + (Sex x 3.825) + (Age x -0.071)] + 
5.102 
where height is in cm; BIA-resistance is in ohms; sex is coded men=1 and 
women=0; and age is in years. Absolute skeletal muscle mass (kg) was then 
converted to percentage skeletal muscle mass and termed skeletal muscle index 
(SMI) as follows: 
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SMI (%SMM) = skeletal muscle mass / body mass * 100  
Subjects were considered to have a normal SMI if their SMI was within one 
standard deviation below the sex-specific mean for young adults (ages 18–39). 
We used the sex-specific mean SMI for young adults calculated by Janssen and 
colleagues as reference because of a higher number of subjects in their 
population (n= 3298 women and 3116 men). The mean SMI (%SMM) in 18–39 
year men was 42.5% ± 5.5% and 33.1% ± 5.5% in 18–39 year women. In our study, 
low %SMM was considered as <36 for men and <26 for women, respectively. 
And high %SMM was considered as ≥36% for men and ≥26% for women 
according to sensitivity analysis.   
Statistical analysis 
There are two analytical aims for this study: 1.) to estimate the independent effect 
of vitamin D and calcium on functional outcomes in FOS subjects, aged 50 and 
above; 2.) to determine whether BMI, physical activity, and skeletal muscle mass 
(SMM) modify the effect of vitamin D and calcium on functional status over 
time.  
We used sensitivity analysis to classify vitamin D intakes into three categories as 
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follows: <160 IU, 160–<280 IU, and ≥280 IU. Likewise, calcium intakes was 
classified as <500 mg, 500–<800 mg, and ≥800mg. 
Functional outcomes measurement   
For each of seven selected functional tasks from the Rosow-Breslau and Nagi 
scales, subjects were categorized as “able to do / independent” or “unable to do / 
dependent”. 
The Rosow-Breslau Scale tasks (e.g., heavy work around the house) entail 
dichotomous responses (the subject responds either “can do” or “can’t do”). 
Thus, these responses were used to classify subjects directly as dependent 
(unable) or independent (able). For the Nagi scale, there were 5 possible response 
categories. For these analyses, the categories were collapsed to reflect whether 
the subject was independent (able) or dependent (unable). Those who responded 
that they had “a lot of difficulty” or were ”unable to do” a particular task were 
considered dependent while subjects who responded “no difficulty”, “a little 
difficulty” or “some difficulty” were considered independent on those tasks.  
For most analyses, we included subjects who were independent in the 7 selected 
tasks at exam 5 and who were followed prospectively through exams 6, 7, and 8 
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to estimate the incidence of functional decline in each vitamin D and calcium 
intake group over time. 
To assess the overall risk of functional decline, we also created a weighted 
composite score based on the 7 selected tasks from the Rosow-Breslau and Nagi 
scales. These tasks were weighted on the basis of the level of strength and/or 
endurance needed to complete the task. The Rosow-Breslau Scale tasks were 
scored as follows: (a) heavy work around the house (washing windows walls or 
floors, shoveling) - 0 points for unable, 4 points for able; (b) able to walk up and 
down stairs to second floor - 0 points for unable, 3 points for able; and (c) able to 
walk half a mile (about 4–6 blocks) – 0 points for unable, 4 points for able. For the 
Nagi Scale, the tasks were scored as follows: (a) pulling or pushing large objects 
(e.g. living room chair) – 0 points for unable, 1 for a lot of difficulty, 2 for some 
difficulty, 3 for a little difficulty, and 4 points for no difficulty; (b) stooping, 
crouching, kneeling - 0 to 4 points as for previous task; (c) lifting or carrying 
weights under 10 pounds (bag of potatoes) - 0 points for unable, 0.5 points for a 
lot of difficulty, 1 for some difficulty, 1.5 points for a little difficulty, and 2 points 
for no difficulty; and (d) lifting or carrying weights over 10 pounds (heavy bag of 
groceries) – 0 to 4 points as before. The total functional score (ranging from 0 to 
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25 points) was the sum of points for all 7 tasks from the two scales. 
Initially, the baseline characteristics of subjects according to vitamin D and 
calcium intake at exams 3 and 5 were compared using means and proportions 
across groups. The univariable association between vitamin D and calcium 
intake and prevalence of functional disabilities were analyzed using Mantel 
Haenszel chi-square analyses. The multivariate association of vitamin D and 
calcium intake on physical functioning outcomes were analyzed using Cox 
proportional hazards models, and repeated-measures longitudinal models. 
Follow-up time was censored at the first of the following events: 1.) last exam 
cycle (8); 2.) development of functional disability; 3.) lost to follow-up; or 4.) 
death. 
To assess effect modification of vitamin D and calcium by BMI on functional 
outcomes, BMI was categorized as ≥28 vs. <28 and cross-classified with 
dichotomous vitamin D (<160 IU/d vs. ≥160 IU/d) and calcium intake (<500 mg/d 
vs. ≥500 mg/d). Similarly, vitamin D and calcium intake was cross-classified with 
dichotomous physical activity level (categorized as the lowest two sex-specific 
quintiles of activity vs. the upper three quintiles of activity). Lastly, effect 
modification by SMM was examined with SMM dichotomized as “Low” vs. 
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“High”. In our study, low %SMM was considered as <36 for men and <26 for 
women. High %SMM was considered as ≥36% for men and ≥26% for women 
according to sensitivity analysis.  All statistical analyses were carried out using 
SAS 9.3 program.  
4.3. Results 
Table 4.1 shows background characteristics of subjects according to three 
categories of calcium intake: <500 mg, 500–<800 mg, and ≥800 mg/day. Those 
with the highest calcium intakes were taller and weighed more but had lower 
BMIs than those with lower intakes. Higher calcium was associated with a higher 
vitamin D intake and higher weight-adjusted intakes of dietary protein.  
  
117 
 
Table 4.1. Baseline characteristics according to calcium intake 
 Calcium intake  
  <500 mg 500 –<800 mg ≥800 mg   
  n=476 n=840 n=578   
  Mean ± s.d. p value1 
Age (yrs)  57.1 ± 6.2 56.5 ± 5.8 56.2 ± 5.7 0.0494 
Height (cm)  165 ± 9 166 ± 9 171 ± 9 <0.0001 
Weight (kg) 74.6 ± 16.9 74.9 ± 14.9 79.3 ± 15.5 <0.0001 
BMI (kg/m2) 27.3 ± 5.2 27.0 ± 4.5 26.9 ± 3.9 0.3549 
Physical Activity  12.2 ± 8.4 12.8 ± 8.3 13.5 ± 9.4 0.0350 
Cigarettes/day 4.4 ± 9.9 3.1 ± 8.7 4.4 ± 10.9 0.0154 
Alcohol intake (gm/week) 11.8 ± 19.0 10.3 ± 15.4 11.5 ± 16.7 0.2052 
Nutrient Intakes       
  Energy, kcal 1494 ± 324 1794 ± 417 2230 ± 513 <0.0001 
  % of calorie from protein 17.5 ± 3.5 17.2 ± 3.2 16.8 ± 2.9 0.0004 
  % calories from fat 34.5 ± 6.7 34.3 ± 6.5 34.5 ± 6.5 0.7881 
  % calories from carbs  45.5 ± 8.1 47.1 ± 7.7 47.6 ± 7.8 <0.0001 
  Calcium (mg) 404 ± 729 641 ± 86 1061 ± 270 <0.0001 
  Vitamin D (IU) 132 ± 66 194 ± 111 297 ± 134 <0.0001 
  Protein per kg body wt 0.9 ± 0.2 1.0 ± 0.3 1.2 ± 0.3 <0.0001 
  Protein (wt-adjusted)2 65.3 ± 15 76.7 ± 17.1 90.7 ± 20.5 <0.0001 
  Column Percent   
Education (% college) 17.7% 27.0% 30.8% 0.0001 
Sex (% male) 33.2% 42.9% 64.5% 0.0001 
     1 p-values compare means and proportions across groups (ANOVA and Mantel-Haenszel Chi-Square) 
    2 Protein intake adjusted for body weight, using residual method 
 
In Table 4.2, we compare the number and percent of subjects who were 
dependent in 7 selected functional tasks according to calcium intakes at exams 5–
8. There was some tendency for subjects with the highest calcium intakes to have 
a lower prevalence of difficulty doing heavy work at home and walking one-half 
mile (particularly in later exam cycles). 
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We then looked at the subset of individuals who were independent at exam 5 
and followed them forward to determine whether the prevalence of developing 
functional difficulties differed by intake of dietary calcium. In Table 4.3, a lower 
proportion of subjects with higher calcium intake categories developed 
functional difficulties (in heavy work at home, walking ½ mile, and 
pushing/pulling heavy objects) compared with subjects consuming less calcium. 
To adjust for potential confounding by sex, age, education, physical activity, 
cigarettes smoked per day, height, BMI, and energy intake, we used Cox 
proportional hazard’s models to estimate the hazard ratios for developing 
functional disabilities by exam 8. Table 4.4 shows the subjects (who were 
independent in selected functional tasks at Exam 5) who consumed 800 mg of 
calcium (vs. <500 mg) had a non-statistically significant reduced risk of becoming 
dependent in heavy work at home, walking ½ mile, and lifting >10 lbs.   
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Table 4.2. Number (%) of subjects unable to complete selected functional tasks at 
exam 5 through 8, according to calcium intake 
 Calcium intake per day 
  <500 mg 500–<800 mg ≥800mg <500 mg 500–<800 mg ≥800mg 
  Exam  5  Exam 6  
  n=458 n=823 n=555 n=413 n=740 n=512 
Rosow-Breslau N (% unable) N (% unable) 
Heavy work 39 (8.5%) 88 (10.7%) 35 (6.3%) 33 (8.0%) 51 (6.9%) 30 (5.9%) 
p for trend1 0.1632 0.2017 
Walk 1/2 mile 16 (3.5%) 24 (2.9%) 15 (2.7%) 14 (3.4%) 29 (3.9%) 17 (3.3%) 
p for trend 0.4706 0.9200 
Stairs 13 (2.8%) 18 (2.2%) 13 (2.3%) 6 (1.5%) 16 (2.2%) 7 (1.4%) 
p for trend 0.6322 0.8551 
Nagi          
Push/Pull 18 (3.9%) 34 (4.1%) 19 (3.4%) 16 (3.9%) 29 (3.9%) 18 (3.5%) 
p for trend 0.6532 0.7629 
Stoop/Kneel 26 (5.7%) 59 (7.2%) 28 (5.1%) 23 (5.6%) 48 (6.5%) 31 (6.1%) 
p for trend 0.6029 0.7902 
Lift <10 lbs 2 (0.44%) 4 (0.49%) 3 (0.54%) 2 (0.48%) 5 (0.68%) 3 (0.59%) 
p for trend 0.8131 0.8626 
Lift >10 lbs. 14 (3.1%) 24 (2.9%) 16 (2.9%) 15 (3.6%) 28 (3.8%) 8 (1.6%) 
p for trend 0.8737 0.0549 
  Exam 7  Exam 8  
 n=401 n=729 n=494 n=330 n=579 n=402 
Rosow-Breslau N (% unable) N (% unable) 
Heavy work 40 (10.0%) 76 (10.4%) 34 (6.9%) 69 (20.9%) 105 (18.1%) 73 (18.2%) 
p for trend 0.0912 0.3648 
Walk 1/2 mile 25 (6.23%) 35 (4.80%) 
16 
(3.24%) 
58 (17.6%) 88 (15.2%) 47 (11.7%) 
p for trend 0.0341 0.0239 
Stairs  3 (0.75%) 12 (1.7%) 4 (0.81%) 24 (7.3%) 49 (8.5%) 23 (5.7%) 
p for trend 0.9781 0.3724 
Nagi          
Push/Pull  15 (3.7%) 34 (4.7%) 12 (2.4%) 30 (9.1%) 43 (7.4%) 18 (4.5%) 
p for trend 0.2524 0.0132 
Stoop/Kneel 29 (7.2%) 54 (7.4%) 23 (4.7%) 44 (13.3%) 86 (14.9%) 41 (10.2%) 
p for trend 0.1015 0.1729 
Lift <10 lbs 5 (1.3%) 5 (0.69%) 1 (0.20%) 8 (2.4%) 17 (2.9%) 8 (2.0%) 
p for trend 0.0585 0.6682 
Lift >10 lbs. 12 (3.0%) 32 (4.4%) 10 (2.0%) 25 (7.6%) 40 (6.9%) 19 (4.7%) 
p for trend 0.3411 0.1084 
1 p for trend derived from Mantel-Haenszel Chi-Square test 
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Table 4.3. Number (%) who became dependent in selected tasks over 12 
 years by exam 8, according to calcium intake 
  Categories of calcium intake 
Functional Status N1 <500 mg 500 – <800 mg ≥ 800 mg 
   Number becoming Dependent by Exam 8  
Rosow-Breslau      
Heavy work at home  1511 71 (19.1%) 98 (14.7%) 69 (14.7%) 
p for trend1  0.0979 
Walk 1/2 mile 1583 63 (16.4%) 95 (13.3%) 49 (10.2%) 
p for trend1  0.007 
Stairs (up and down) 1594 24 (6.2%) 51 (7.1%) 21 (4.3%) 
p for trend1  0.2070 
Nagi      
Push/Pull heavy obj 1572 31 (8.1%) 43 (6.1%) 18 (3.7%) 
p for trend1  0.0069 
Stoop/Kneel/Crouch 1538 37 (9.8%) 77 (11.2%) 42 (8.9%) 
p for trend1  0.6132 
Lift <10 lbs. 1617 9 (2.3%) 20 (2.7%) 8 (1.6%) 
p for trend1  0.4748 
Lift >10 lbs. 1586 27 (6.9%) 43 (6.0%) 22 (4.6%) 
p for trend1  0.1288 
   1 p for trend derived from Mantel-Haenszel Chi-Square test  
 
 
Table 4.4. Risk of becoming dependent in individual functional tasks over 12 
years, according to calcium intake 
 Risk of becoming dependent between Exam 5 and 8 
 Calcium intake per day 
Functional Tasks <500 mg 500–<800 mg ≥800mg 
  Ref HR1  (95% CI) HR1  (95% CI) 
  All Subjects 
Heavy work at home 1.00 0.76 (0.57 – 1.00) 0.87 (0.61 – 1.23) 
Walk a half mile 1.00 0.92 (0.68 – 1.24) 0.83 (0.55 – 1.24) 
Flight of stairs 1.00 1.30 (0.84 – 1.99) 0.90 (0.50 – 1.62) 
Push/Pull heavy obj 1.00 1.05 (0.70 – 1.56) 1.11 (0.64 – 1.91) 
Stoop, Kneel, Crouch 1.00 0.98 (0.70 – 1.37) 1.05 (0.69 – 1.61) 
Lift >10 lbs. 1.00 1.01 (0.66 – 1.53) 0.85 (0.48 – 1.49) 
Lift <10 lbs. 1.00 1.25 (0.61 – 2.56) 1.20 (0.44 – 3.22) 
   1 Adjusted for sex, age, education, activity, cigarettes per day, height, BMI, and energy intake 
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Table 4.5 shows the effect of calcium intake on risk of becoming dependent in ≥1 
and ≥2 functional tasks between exams 5 and 8. Subjects who consumed 800 mg 
or more of calcium intake per day (vs. <500 mg) had 9–16% reduced risk of 
developing functional dependence over 12 years of follow. None of these risk 
reductions were statistically significant.  
Table 4.5. Risk of becoming dependent in ≥1 and ≥2 functional tasks over 12 
years, according to calcium intake 
 
 Risk of becoming dependent between Exam 5 and 8 
 Calcium intake per day  
  <500 mg 500 –<800 mg ≥800 mg 
 Ref HR1 (95% CI)  HR (95% CI)  
 Risk of Becoming Dependent in ≥1 Task 
All subjects 1.00 0.80 (0.64 – 1.01) 0.91 (0.68 – 1.21) 
Men 1.00 0.93 (0.62 – 1.40) 0.87 (0.55 – 1.38) 
Women 1.00 0.76 (0.57 – 1.01) 1.00 (0.69 – 1.44) 
 Risk of Becoming Dependent in ≥2 Tasks 
All subjects 1.00 0.94 (0.70 – 1.26) 0.84 (0.57 – 1.24) 
Men 1.00 0.97 (0.55 – 1.73) 0.66 (0.34 – 1.28) 
Women 1.00 0.91 (0.64 – 1.28) 0.97 (0.60 – 1.57) 
 
1 Adjusted for sex, age, education, activity, cigarettes per day, height, BMI, and energy intake 
 
 
We explored the possibility of effect modification by physical activity as well as 
BMI and %SMM in Tables 4.6–4.8. Based on Table 4.6, we see that there does 
appear to be effect modification of the calcium effect by activity. In the overall 
group (men and women combined), consuming 500 mg or more of calcium per 
day and being more physically active were both independently associated with 
122 
 
about a 15% lower risk of developing at least one disability over 12 years. In 
contrast, the combined effect of higher activity and higher calcium intake (vs. 
low activity and low calcium intake) was a 33% reduction in risk of developing 
one or more disabilities (and a 37% reduced risk of becoming dependent in ≥2 
functional tasks. Similarly, there were protective effects for both men and 
women.  
Table 4.6. Risk of becoming dependent in ≥1 and ≥2 functional tasks according 
to combined effects of calcium intake and physical activity 
 
Exposure group All Subjects Men only Women only 
 HR1 (95% CI)  HR (95% CI)  HR (95% CI)  
 HR of becoming dependent in  ≥ 1 functional task 
Low Activity2, Calcium <500 Ref  Ref  Ref  
Low Activity, Calcium ≥500 0.85 (0.62 – 1.17) 0.79 (0.45 – 1.39) 0.88 (0.60 – 1.31) 
High Activity2, Calcium <500 0.83 (0.59 – 1.17) 0.71 (0.37 – 1.36) 0.85 (0.57 – 1.28) 
High Activity, Calcium ≥500 0.67 (0.50 – 0.92) 0.69 (0.39 – 1.21) 0.66 (0.45 – 0.95) 
 HR of becoming dependent in ≥ 2 functional tasks 
Low Activity, Calcium <500 Ref  Ref  Ref  
Low Activity, Calcium ≥500 0.78 (0.53 – 1.15) 0.58 (0.28 – 1.20) 0.86 (0.54 – 1.38) 
High Activity, Calcium <500 0.58 (0.37 – 0.91) 0.38 (0.14 – 0.98) 0.68 (0.41 – 1.12) 
High Activity, Calcium ≥500 0.63 (0.44 – 0.92) 0.49 (0.24 – 1.01) 0.67 (0.43 – 1.04) 
1 Adjusted for sex (all subjects), age, education, cigarettes, height, BMI and energy intake 
2 Low activity is the lowest two sex-specific quintiles of physical activity, high activity is the upper three 
sex-specific quintiles 
 
 
In Table 4.7, subjects with higher calcium intake and BMI <28 (vs. low calcium 
intake and BMI ≥28) had reduced a reduced risk (52% and 42%, respectively) of 
becoming dependent in ≥1 and ≥2 functional tasks. Protective effects were 
somewhat stronger among women than men.  
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Table 4.7 Risk of becoming dependent in functional tasks according to 
combined effects of calcium intake and BMI 
 
 
 
 
 
 
Table 4.8 shows that a higher %SMM is a major determinant of the risk of 
becoming dependent in ≥1 functional tasks over 12 years. In women, calcium 
intakes ≥500 mg (vs. <500 mg) strengthened slightly the beneficial effects of 
SMM.  
Table 4.8. Risk of becoming dependent in functional tasks according to combined 
effects of calcium intake and % skeletal muscle mass 
  Men Women 
 HR (95% CI) HR (95% CI) HR (95% CI) 
Low SMM1; calcium <500 mg Ref   Ref   Ref   
Low SMM; calcium ≥500 mg 0.88 (0.64–1.19) 0.87 (0.51–1.48) 0.90 (0.62–1.33) 
High SMM; calcium <500 mg 0.59 (0.41–0.85) 0.49 (0.22–1.08) 0.58 (0.38–0.88) 
High SMM; calcium ≥500 mg 0.54 (0.39–0.73) 0.63 (0.37–1.08) 0.49 (0.33–0.72) 
1 Low vs. high %SMM: <36 vs. ≥36% for men; <26% vs. ≥26% for women 
Figure 4.1 shows the longitudinal effects of calcium intakes on the composite 
physical functional task score from exams 5 to 8 using repeated measures mixed 
Exposure Group All Subjects Men only Women only 
 
HR1 95% CI  HR 95% CI  HR 95% CI  
 
HR for becoming dependent in  ≥ 1 functional task 
BMI ≥28, calcium<500 Ref 
 
Ref 
 
Ref 
 
BMI ≥28, calcium ≥500 0.81 (0.59–1.12) 0.86 (0.52–1.42) 0.81 (0.52–1.24) 
BMI<28, calcium<500 0.56 (0.40–0.79) 0.57 (0.29–1.10) 0.53 (0.35–0.81) 
BMI<28, calcium ≥500 0.48 (0.35–0.65) 0.53 (0.32–0.87) 0.46 (0.31–0.68) 
 
HR for becoming dependent in ≥ 2 functional tasks 
 
HR 95% CI  HR 95% CI  HR 95% CI  
BMI ≥28, calcium<500 Ref 
 
Ref 
 
Ref 
 
BMI ≥28, calcium ≥500 0.81 (0.53–1.23) 0.74 (0.34–1.61) 0.94 (0.57–1.55) 
BMI<28, calcium<500 0.57 (0.36–0.89) 0.87 (0.34–2.22) 0.48 (0.29–0.81) 
BMI<28, calcium ≥500 0.58 (0.39–0.85) 0.84 (0.40–1.79) 0.47 (0.30–0.76) 
1 Adjusted for sex, age, education, activity, cigarettes, height, and energy intake. 
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linear regression models. While the results of this analysis are not particularly 
consistent, it seems that over time, subjects with calcium intakes ≥ 800 mg/d had 
slightly higher functional performance scores.  
Figure 4.1. Functional status score by exam cycle according to calcium intake 
among all subjects 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
 
Vitamin D and Functional Status 
Starting with Table 4.9, we show the effects of vitamin D on the same set of 
functional outcomes. At baseline, those with lower vitamin D intakes had lower 
heights and weight and consumed less total energy, calcium, and protein.  
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Table 4.9. Baseline characteristics according to vitamin D intake 
 
 Vitamin D Intake 
  <160 IU 160 – <280 IU ≥ 280 IU   
  n=756 n=732 n=406   
  Mean ± s.d. p value1 
Age (yrs) 56.4 ± 5.8 56.4 ± 6.0 57.0 ± 5.8 0.2357 
Height (cm) 166 ± 9 168 ± 9 171 ± 9 <0.0001 
Weight (kg) 74.2 ± 15.6 76.9 ± 15.7 78.4 ± 15.6 <0.0001 
BMI (kg/m2) 27.0 ± 4.7 27.3 ± 4.6 26.8 ± 4 0.1681 
Physical Activity  12.9 ± 8.7 13.1 ± 8.8 12.5 ± 8.6 0.5035 
Cigarettes/day 4.1 ± 9.7 3.8 ± 9.8 3.4 ± 9.7 0.5162 
Alcohol intake (gm/day) 11.0 ± 18.3 11.1 ± 15.8 11.0 ± 15.5 0.9978 
Nutrient Intakes      
  Energy 1660 ± 422 1872 ± 484 2180 ± 536 <0.0001 
  % calories from protein 17.0 ± 3.3 17.2 ± 3.2 17.5 ± 3.2 0.0270 
  % calories from fat 34.5 ± 6.5 34.6 ± 6.4 34.0 ± 6.9 0.3090 
  % calories from carbs  46.4 ± 8.1 46.8 ± 7.6 47.7 ± 7.9 0.0298 
  Calcium (mg) 549 ± 186 717 ± 224 997 ± 367 <0.0001 
  Vitamin D (IU) 109 ± 34 214 ± 34 391 ± 138 <0.0001 
  Protein per kg body wt. 1.0 ± 0.3 1.1 ± 0.3 1.2 ± 0.3 <0.0001 
  Protein (wt.-adjusted)2 70.1 ± 17.2 78.6 ± 18.5 92.3 ± 20.1 <0.0001 
  Column Percent   
Education (% college) 22.8% 26.2% 30.8% 0.0008 
Sex (% male)  38.0% 47.5% 63.1% <0.0001 
 
1 p-value from ANOVA (means) and Mantel- Haenszel Chi-Square (proportions) 
2 Protein intake adjusted for body weight, using residual method 
 
 
In bivariate analysis (Table 4.10), we looked at the proportion of subjects 
dependent in 7 selected functional tasks according to vitamin D intake at 
sequential exams 5 through 8. Results show that subjects with higher vitamin D 
(vs. lowest vitamin D) intakes tended to have a lower risk of being unable to 
walk ½ mile, push/pull heavy objects, or stoop/kneel/crouch.   
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Table 4.10. Number (%) of subjects who are dependent in selected functional 
tasks according to vitamin D intake 
 Vitamin D intake per day 
Functional Status <160 IU 160–<280 IU ≥ 280 IU <160 IU 160–<280 IU ≥ 280 IU 
  Exam  5  Exam 6  
  n=735 n=706 n=395 n=669 n=644 n=352 
Rosow-Breslau  N (% unable) N (% unable) 
Heavy work  69 (9.4%) 67 (9.5%) 26 (6.6%) 47 (7.0%) 43 (6.7%) 24 (6.8%) 
p for trend1 0.1607 0.8686 
Walk 1/2 mile 20 (2.7%) 25 (3.5%) 10 (2.5%) 22 (3.3%) 29 (4.5%) 9 (2.6%) 
p for trend 0.9735 0.7850 
Stairs  17 (2.3%) 20 (2.8%) 7 (1.8%) 10 (1.5%) 16 (2.5%) 3 (0.9%) 
p for trend 0.7110 0.7154 
Nagi           
Push/Pull  33 (4.5%) 29 (4.1%) 9 (2.9%) 26 (3.9%) 25 (3.9%) 12 (3.4%) 
p for trend 0.0850 0.7346 
Stoop/Kneel 48 (6.5%) 43 (6.1%) 22 (5.6%) 47 (7.0%) 41 (6.4%) 14 (4.0%) 
p for trend 0.5182 0.0678 
Lift <10 lbs. 4 (0.5%) 4 (0.6%) 1 (0.3%) 5 (0.8%) 4 (0.6%) 1 (0.3%) 
p for trend 0.5590 0.3816 
Lift >10 lbs. 28 (3.8%) 21 (3.0%) 5 (1.3%) 28 (4.2%) 18 (2.8%) 5 (1.4%) 
p for trend 0.0185 0.0129 
  Exam 7  Exam 8  
  n=659 n=619 n=346 n=536 n=499 n=276 
Rosow-Breslau  N (% unable) N (% unable) 
Heavy work  60 (9.1%) 63 (10.2%) 27 (7.8%) 99 (18.5%) 92 (18.4%) 56 (20.3%) 
p for trend 0.6459 0.5790 
Walk 1/2 mile 36 (5.5%) 26 (4.2%) 14 (4.1%) 87 (16.2%) 71 (14.2%) 35 (12.7%) 
p for trend 0.2575 0.1603 
Stairs  11 (1.7%) 5 (0.81%) 3 (0.87%) 42 (7.8%) 36 (7.2%) 18 (6.5%) 
p for trend 0.1895 0.4900 
Nagi          
Push/Pull  29 (4.4%) 25 (4.0%) 7 (2.0%) 44 (8.2%) 31 (6.2%) 16 (5.8%) 
p for trend 0.0797 0.1557 
Stoop/Kneel 48 (7.3%) 42 (6.8%) 16 (4.6%) 80 (14.9%) 62 (12.4%) 29 (10.5%) 
p for trend 0.1276 0.0659 
Lift <10 lbs. 7 (1.1%) 4 (0.7%) 0 (0.0%) 12 (2.2%) 12 (2.4%) 9 (3.3%) 
p for trend 0.0530 0.4121 
Lift >10 lbs. 22 (3.3%) 19 (3.1%) 13 (3.8%) 38 (7.1%) 27 (5.4%) 19 (6.9%) 
p for trend 0.7984 0.7289 
1 p-values from Mantel-Haenszel Chi Square test 
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Table 4.11 explores the effect of vitamin D intake among subjects who were 
independent in selected functional tasks at Exam 5 and became dependent at 
Exam 8. Here, there was little effect of vitamin D on risk of functional decline in 
these individual tasks although subjects with higher intakes of vitamin D (160 – 
<280 IU and ≥ 280 IU) at baseline were slightly less likely to have functional 
decline in some tasks (e.g., walking ½ mile, pushing/pulling heavy objects), than 
those with lower vitamin D intakes.  
Table 4.11. Number (%) of subjects who were independent at exam 5 and 
became dependent in selected functional tasks by exam 8, according to vitamin 
D intake 
  Categories of vitamin D intake 
Functional Status N1 <160 IU 160 – <280 IU ≥ 280 IU 
   Number (%) becoming dependent by Exam 82 
Rosow-Breslau      
Heavy work  1511 99 (16.2%) 84 (14.8%) 55 (16.6%) 
p for trend1  0.9809 
Walk 1/2 mile 1583 93 (14.4%) 72 (12.1%) 42 (12.4%) 
p for trend  0.2846 
Stairs  1594 44 (6.8%) 34 (5.7%) 18 (5.2%) 
p for trend  0.2942 
Nagi      
Push/Pull heavy objects 1572 46 (7.2%) 29 (4.9%) 17 (5.0%) 
p for trend  0.0997 
Stoop/Kneel/Crouch 1538 67 (10.8%) 57 (9.7%) 32 (9.7%) 
p for trend  0.5517 
Lift <10 lbs. 1617 16 (2.4%) 12 (2.0%) 9 (2.6%) 
p for trend  0.9719 
Lift >10 lbs. 1586 38 (5.9%) 29 (4.8%) 25 (7.3%) 
p for trend  0.5474 
1 P values from the Mantel-Haenszel Chi-Square test 
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After adjusting for potential confounding, Table 4.12 shows that there was still 
no effect of vitamin D on these functional tasks.  
Table 4.12. Risk of functional decline in individual tasks according to  
vitamin D intake 
 Risk of Becoming Dependent between Exam 5 and 8 
Functional Task <160 IU 160 – <280 IU ≥ 280 IU 
  Ref HR1 (95% CI) HR  (95% CI) 
  All Subjects 
Heavy Work at Home 1.00 0.99 (0.76–1.27) 1.08 (0.79–1.49) 
Walk a Half Mile 1.00 1.11 (0.84–1.47) 0.92 (0.63–1.32) 
Flight of Stairs 1.00 1.25 (0.86–1.83) 0.89 (0.52–1.52) 
Push/Pull Heavy Obj. 1.00 0.79 (0.54–1.16) 1.21 (0.75–1.95) 
Stoop, Kneel, Crouch 1.00 0.97 (0.72–1.30) 0.86 (0.58–1.28) 
Lift >10 lbs. 1.00 0.83 (0.56–1.24) 1.30 (0.82–2.07) 
Lift <10 lbs. 1.00 0.82 (0.43–1.58) 1.12 (0.50–2.53) 
1. Adjusted for sex, age, education, activity, cigarettes per day, height, BMI, and energy intake 
To increase the power of the analysis, we explored collapsing vitamin D intake 
into two categories rather than three. Table 4.13 shows the effect of ≥ 280 IU 
vitamin D (vs. <280 IU) was still very imprecise and inconsistent. Similarly, Table 
4.14 shows that there was no apparent association between vitamin D intakes 
and the risk of developing multiple functional disabilities over 12 years of follow 
up. 
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Table 4.13. Risk of functional decline in individual tasks according to vitamin 
D intake (≥ 280 IU/d vs. <280 IU/d) 
  Risk of Becoming Dependent 
between Exam 5 and 8 
Functional Task <280 IU ≥ 280 IU 
  Ref HR1 (95% CI) 
  All Subjects 
Heavy Work at Home 1.00 1.09 (0.82 – 1.45) 
Walk a Half Mile 1.00 0.86 (0.62 – 1.20) 
Flight of Stairs 1.00 0.79 (0.48 – 1.28) 
Push/Pull Heavy Objects 1.00 1.35 (0.86 – 2.10) 
Stoop, Kneel, Crouch 1.00 0.88 (0.62 – 1.26) 
Lift >10 lbs. 1.00 1.43 (0.94 – 2.18) 
Lift <10 lbs. 1.00 1.23 (0.58 – 2.63) 
 1 Adjusted for sex, age, education, activity, cigarettes per day, height, BMI, and energy intake 
Table 4.14. Risk of becoming dependent in ≥1 and ≥2 functional tasks, 
according to vitamin D intake  
 Vitamin D Intake 
  <160 IU 160 – <280 IU ≥ 280 IU 
  Ref HR1 (95% CI)  HR (95% CI)  
  Risk of becoming dependent in ≥1 Task 
  
All Subjects 1.00 1.02 (0.83 – 1.25) 1.00 (0.77 – 1.30) 
Men 1.00 1.04 (0.73 – 1.46) 0.86 (0.58 – 1.29) 
Women 1.00 1.03 (0.79 – 1.34) 1.16 (0.81 – 1.65) 
  Risk of becoming dependent in ≥2 Tasks 
All Subjects 1.00 1.07 (0.82 – 1.40) 1.01 (0.72 – 1.43) 
Men 1.00 0.93 (0.57 – 1.53) 0.74 (0.42 – 1.30) 
Women 1.00 1.10 (0.80 – 1.51) 1.20 (0.76 – 1.88) 
111 Adjusted for sex, age, education, activity, cigarettes, height, BMI, and energy intake. 
 
Finally, we explored potential effect modification by physical activity, BMI, and 
%SMM in Tables 4.15–4.17. In the first of these tables, it is evident that there is no 
effect modification by physical activity. What we do see in this table is that high 
levels of physical activity, regardless of vitamin D intakes, were associated with a 
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lower risk of becoming dependent in ≥ 1 and ≥ 2 functional tasks. High vitamin D 
intake alone was not associated with risk of functional disability in this analysis. 
Table 4.15. Risk of becoming dependent in functional tasks according to the 
combined effects of vitamin D intake and physical activity  
Exposure Group All Subjects Men Only Women Only 
  HR1 (95% CI)  HR (95% CI)  HR (95% CI)  
  Risk for becoming dependent in ≥ 1 functional task 
Low Activity2, Vit. D <160 Ref         
Low Activity, Vit. D ≥160 1.09 (0.82–1.44) 0.74 (0.47–1.18) 1.40 (0.97–2.01) 
High Activity, Vit. D <160 0.86 (0.65–1.10) 0.63 (0.38–1.03) 0.98 (0.69–1.39) 
High Activity, Vit. D ≥160 0.83 (0.63–1.08) 0.73 (0.47–1.14) 0.86 (0.60–1.22) 
  Risk for becoming dependent in ≥ 2 functional tasks 
Low Activity, Vit. D <160 Ref         
Low Activity, Vit. D ≥160 0.99 (0.70–1.42) 0.52 (0.28–0.96) 1.40 (0.90–2.18) 
High Activity, Vit. D <160 0.70 (0.49–0.99) 0.38 (0.19–0.77) 0.90 (0.58–1.38) 
High Activity, Vit. D ≥160 0.77 (0.55–1.09) 0.53 (0.30–0.94) 0.86 (0.56–1.32) 
1 Adjusted for sex (all subjects), age, education, cigarettes, height, BMI, and energy intake 
2 Low activity: Q1–Q2 vs. Q3–Q5.  
 
There is also no evidence of effect modification by BMI in Table 4.16. However, 
subjects whose BMI was <28 had lower risks of functional decline, regardless of 
vitamin D intake. Among heavier subjects (BMI ≥28) with vitamin D intake ≥160 
IU there about a 20% non-statistically significant reduced risk of developing 
multiple functional disabilities. In the final table exploring effect modification in 
this section (Table 4.17), we also see that there is no effect modification by 
%SMM.   
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Table 4.16. Risk of becoming dependent in functional tasks according to 
independent and combined effects of vitamin D intake and BMI 
 
Exposure Group All Subjects Men only Women only 
  HR1 95% CI  HR 95% CI  HR 95% CI  
  HR for becoming dependent in  ≥ 1 functional task 
BMI ≥28, Vit. D <160 Ref 
  
  Ref 
  
  Ref 
  
  
BMI ≥28, Vit. D ≥160 0.80 0.60 – 1.07 0.89 0.59 – 1.37 0.73 0.48 – 1.11 
BMI <28, Vit. D <160 0.47 0.35 – 0.62 0.54 0.33 – 0.89 0.42 0.29 – 0.60 
BMI <28, Vit. D ≥160 0.54 0.41 – 0.71 0.57 0.37 – 0.86 0.52 0.36 – 0.74 
  HR for becoming dependent in  ≥ 2 functional tasks 
BMI ≥28, Vit. D <160 Ref 
  
  Ref 
  
  Ref 
  
  
BMI ≥28, Vit. D ≥160 0.78 0.53 – 1.15 0.76 0.39 – 1.49 0.88 0.54 – 1.43 
BMI <28, Vit. D <160 0.52 0.36 – 0.74 0.98 0.49 – 1.95 0.42 0.27 – 0.65 
BMI <28, Vit. D ≥160 0.63 0.44 – 0.88 0.89 0.48 – 1.64 0.51 0.33 – 0.77 
1 Adjusted for sex (all subjects), age, education, activity, cigarettes, height, BMI, and energy intake 
 
Table 4.17. Risk of becoming dependent in ≥ 1 functional tasks according to 
independent and combined effects of vitamin D intake and Skeletal Muscle 
Mass (%SMM) 
 
  Risk of becoming dependent in ≥1 tasks 
Exposure Group All Subjects Men only Women only 
  HR1 95% CI HR 95% CI  HR 95% CI 
Low %SMM2; Vit D<160    Ref   Ref   Ref   
Low %SMM; Vit D≥160 0.97 (0.73–1.29) 0.88 (0.55–1.40) 1.06 (0.74–1.51) 
High %SMM3; Vit D<160 0.55 (0.41–0.75) 0.60 (0.35–1.04) 0.52 (0.36–0.74) 
High %SMM; Vit D≥160 0.62 (0.47–0.81) 0.63 (0.40–1.01) 0.60 (0.43–0.84) 
 
1 Adjusted for age, sex (all subjects), height, physical activity, cigarette smoking per day, and energy intake 
2 Low %SMM = <36 and <26 for men and women, respectively 
3 High %SMM = ≥36 and ≥26 for men and women, respectively 
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Figure 4.2. shows the longitudinal effect of vitamin D intakes on composite 
physical functional tasks score from Exam 5 to Exam 8. There was no statistically 
significant association between vitamin D intake and the composite functional 
score. The results were the same for men and women. 
Figure 4.2 Functional status score by exam cycle according to vitamin D intake 
among all subjects 
  
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
 
4.5. Discussion 
Higher intakes of dietary calcium were associated with a reduced risk of 
becoming dependent in some of the functional tasks among the study population 
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in bivariate analysis over 12 years of follow up. Vitamin D was only weakly 
associated with better functional status and no results achieved statistical 
significance. In the multivariate analysis, effects of vitamin D were further 
attenuated and there was no modification of the vitamin D effects by physical 
activity, BMI, or skeletal muscle mass. Dietary calcium intake, however, was 
associated with some reduction of risk of functional disability in multivariable 
models. There was evidence of effect medication of calcium intake by physical 
activity in particular. Subjects with high activity levels and calcium intake at or 
above 500 mg/day (vs. low activity and calcium <500 mg/day) had a reduced risk 
of becoming dependent in ≥1 functional tasks by 33% (HR 0.67, 95% CI 0.50 – 
0.92) over 12 years of follow-up. Similar reductions in risk were observed both 
among men and women with higher intakes of calcium and high activity levels. 
There were also beneficial independent effects of dietary calcium and physical 
activity. In contrast, this study suggests little if any effect modification of dietary 
calcium by BMI or SMM.  
Previous studies of the effects of vitamin D and calcium intakes on physical 
functioning have found mixed results (139). Some studies found beneficial effects 
while other studies found no effect. In elderly subjects, vitamin D deficiency has 
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been shown to be associated with poorer physical performance, muscle strength, 
and low muscle mass as well as an increased risk of falls (58, 63, 88, 201, 202). 
Vitamin D exerts its effects on skeletal muscle through proximal muscle atrophy, 
type II muscle loss, secondary hyperparathyroidism and regulation of calcium 
transport in the sarcoplasmic reticulum (57, 127, 130, 131, 203, 204). In a clinical 
trial among healthy subjects living in the community aged ≥ 70 year with vitamin 
D level of 16 ng/ml or less, subjects were randomized to exercise or control 
groups. These two groups were further randomized to receive either vitamin D 
400 IU plus 800 mg of calcium per day or calcium alone. Subjects were followed 
for nine months after randomization. Outcome measures included muscle 
strength (hand grip strength), SPPB, quadriceps muscle strength, TUG speed, 
gait speed, body sway, and bone mineral density. Results showed that the 
exercise group had significantly improved muscle strength. TUG speed was 
improved among the combined vitamin supplementation and exercise group 
compared to exercise alone. With vitamin D (400 IU/d) and calcium (800 mg/d) 
supplementation, subjects improved significantly in gait speed and body sway 
(200). Another study demonstrated that vitamin D and calcium supplementation 
led to improvements in quadriceps muscle strength and function (214). 
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In a prospective study of women aged 75 years and older with three years of 
follow up, vitamin D status (measured by 25(OH)D) was correlated with better 
gait speed, less body sway, more self-reported activity, and greater thigh muscle 
strength (202). Other studies conducted among community-dwelling and 
institutional older adults showed that long-term calcium and vitamin D 
supplementation demonstrated improved muscle strength and fall prevention 
(66, 205, 206). Not all studies have shown such beneficial effects on physical 
functioning including some randomized clinical trials. A study of community-
dwelling men, aged 65–87 years, found that vitamin D (1000 IU/day) plus 
calcium (500 mg/day) supplementation (vs. placebo control) for 6 months had no 
effect on muscle strength, physical performance, or 8-foot walk time (207). 
One potential explanation for the absence of an effect of vitamin D intakes on 
physical functioning may be related the low level of vitamin D intake in this 
cohort, particularly among men. The intakes of both vitamin D and calcium 
intake in the FOS were well below the IOM recommendations for adults (209, 
210). Thus these very low intakes could explain the weak (or null) effects in this 
study. It has been well-documented that muscle tissue has vitamin D receptors 
(129). Vitamin D deficiency could lead to reductions in muscle force generation 
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and repletion of vitamin D deficient states could prevent muscle proteolysis 
(211). In addition, studies also shown that vitamin D deficiency may lead to 
atrophy and reduction of type 2 muscle fibers (131). Type 2 muscle fibers are fast-
twitch fibers that contribute to the ability to perform high intensity activities and 
help to maintain balance. Therefore, vitamin D deficiency could contribute to 
limited high-intensity physical functioning and falls in older adults (212). 
Previous studies have also shown that vitamin D supplementation improves 
proximal muscle strength among adults with vitamin D deficiency (213). An 
observational study found that higher vitamin D and calcium status were 
associated with better functional mobility (197). A meta-analysis concluded that 
vitamin D supplementation with or without calcium did not improve grip 
strength or proximal lower limb strength among subjects with adequate vitamin 
D status (i.e., 25(OH)D levels >25 nmol/L). However, this meta-analysis found 
significant improvements in hip muscle strength with vitamin D 
supplementation among subjects whose baseline 25(OH)D level was <25 nmol/L 
(213). 
Study limitations 
There were several limitations of our study and an important one is that our 
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study subjects’ baseline calcium and vitamin D intakes were generally quite low. 
Therefore, it may be that intake levels need to be higher to see any benefits on 
physical functioning outcomes. Another limitation is that all physical functioning 
outcomes were assessed using self-reported functional scales rather than using 
performance-based measures. Since we did not have vitamin D status for the 
subjects in these analyses, we were not able to assess its effect on functional 
outcomes or to determine whether vitamin D deficiency might modify the effects 
of vitamin D or calcium consumption.  
Study strengths 
This is a relatively large cohort with 12 years of follow up of functional status 
change. Vitamin D and calcium intakes were collected using a standard 3-day 
diary method under the supervision of a trained registered dietician. Functional 
outcomes were measured using the well-validated Rosow-Breslau and Nagi 
Scales at each sequential exam cycles of 5, 6, 7, and 8. Finally, another benefit of 
the study is the availability of extensive data on potential confounders and effect 
modifiers of interest.  
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Conclusions 
We have examined the effects of calcium and vitamin D intakes on physical 
functioning over 12 years of follow-up. Physical functioning was evaluated based 
on selected functional tasks from the Rosow-Breslau and Nagi Scales that most 
reflected the need for muscle strength and endurance. This study generally failed 
to detect any significant independent effect of vitamin D on physical functioning 
among the study subjects despite a long-term follow up. However, the study did 
find a suggestion of a beneficial effect of dietary calcium, particularly among 
men and women who were more physically active. Further well-designed 
clinical trials with repeated measures of vitamin D status and adequate 
supplementation of vitamin D and calcium among the subjects with low baseline 
intakes and low blood levels are needed to determine the true effects of vitamin 
D and calcium on functional status change over time.  
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CHAPTER 5: GENERAL DISCUSSION 
By 2050, the US population aged 65 and over is projected to reach 83.7 million, 
doubling the 2012 population of 43.1 million older adults (215). One in five 
Americans is projected to be aged 65 and older by 2030 (216). This aging trend 
presents tremendous challenges in terms of preservation of functional capacity 
and prevention of disability. The associated disease burden and financial costs 
are also expected to rise sharply (69).  Modifiable lifestyle behaviors such as diet 
and physical activity may provide key strategies to optimize physical 
functioning and quality of life of middle-aged and older adults. There are some 
studies suggesting that exercise as well as adequate intake of related nutrients 
such as dietary protein, vitamin D, and calcium can support physical functioning 
by maintaining or strengthening underlying muscle and bone health (39, 54, 122, 
155).  However, there are few studies that have examined the effects of exercise, 
dietary protein, vitamin D, and calcium on functional status and most of these 
are relatively short term. This dissertation presents data on the effects of exercise 
as well as intake of dietary protein, vitamin D, and calcium on physical 
functioning in two distinct populations: a cohort of post-hip fracture subjects and 
a subset of the prospective Framingham Offspring Study. These findings add to 
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the current understanding of the role of physical exercise and diet in the 
preservation of physical function and prevention of age-related disability in 
middle-aged and older adults. 
There are a number of key findings from these analyses. Amongst post-hip 
fracture older adults, it was found that a home-based exercise program following 
formal in-patient rehabilitation significantly and persistently improved measures 
of physical performance compared to the control group which did not receive the 
exercise intervention. In a subset of these older adults, we carried out a pilot 
study to assess the effects of dietary protein, vitamin D and calcium on physical 
functioning. In these analyses, higher intakes of dietary calcium were associated 
with better recovery of functional performance while no association was found 
for vitamin D or dietary protein over 9 months of follow-up.  
In examining the effects of dietary protein on functional status among middle-
aged and older adults in the Framingham Offspring Study (FOS) over 12 years of 
follow up, we found that higher levels of protein intake alone and particularly in 
combination with higher levels of physical activity, lower BMI and higher 
skeletal muscle mass were generally associated with less functional decline over 
time. In specifically estimating the functional effects of consuming amounts at or 
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above (vs. below) the currently recommended dietary allowance (RDA) for 
protein intake of 0.8 gm/kg/day, we found that individuals with intakes at or 
above the RDA had statistically significantly reduced risks of becoming 
dependent in such functional tasks as doing heavy work around the house and 
walking 1/2 mile. These findings add to the growing evidence that the current US 
RDA for protein may be inadequate for older adults.   
Finally, we examined the effects of vitamin D and calcium intakes on physical 
functioning in these same subjects. We found no consistent independent 
beneficial effects of vitamin D on the ability to perform the selected functional 
tasks. However, higher intakes of dietary calcium in subjects with a physically 
active lifestyle led to less functional decline over time. However the effects of 
calcium were weaker than those observed for protein. It is possible that the very 
low baseline intakes of vitamin D and calcium among these study subjects may 
explain the weak or absent effects of these nutrients. Finally, we also found that 
the effects of dietary calcium were modified by both BMI and SMM. 
There is pressing need to identify effective strategies to prevent loss of functional 
capacity in our rapidly aging population. This study makes important 
contributions to the understanding of the role of physical activity and nutrient 
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intake in meeting this challenge in older adults who have suffered a disabling 
event as well as those who are free-living individuals in the community. These 
data support the need for future randomized clinical trials to better understand 
whether and how physical activity and dietary protein (as well as calcium and 
vitamin D) work synergistically to improve the recovery of strength and 
functional performance among older adults suffering from acute disabling 
events. The absence of vitamin D status in our current studies also points to the 
need for such information in future studies since the effects of vitamin D and 
calcium may differ among individuals with prevalent deficiencies. In 
observational studies, dietary effects are often difficult to detect as a result of the 
many problems and biases associated with measurement of diet. Thus, future 
studies with more dietary data and larger sample sizes are needed to provide 
adequate power to evaluate synergistic effects between nutrients and other 
lifestyle factors.  
Finally, this dissertation makes an important contribution to the existing 
evidence that the current Dietary Guidelines for older adults may need to be 
revised upward. It also shows that current intakes of calcium and vitamin D are 
far below recommended intake levels. Thus, future studies of dietary calcium 
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and vitamin D at levels recommended by the Dietary Guidelines will enhance our 
understanding of the role of these nutrients on muscle strength and performance 
in older adults. 
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Figure 1. Functional status score by exam cycle according to calcium & vitamin 
D intake among all subjects 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 2. Functional status score by exam cycle according to calcium intake & 
physical activity among all subjects 
 
 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 3. Functional status score by exam cycle according to vitamin D intake 
& physical activity interaction intake among all subjects 
 
 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 4.  Functional status score by exam cycle according to calcium intake & 
% skeletal muscle mass among all subjects 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 5. Functional status score by exam cycle according to vitamin D intake 
& % skeletal muscle mass among all subjects 
 
  
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 6. Functional status score by exam cycle according to calcium & BMI 
interaction intake among all subjects 
 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy 
intake 
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Figure 7. Functional status score by exam cycle according to vitamin D & BMI 
interaction intake among all subjects 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 8. Functional status score by exam cycle according to calcium intake & 
weight-adjusted protein interaction intake among all subjects 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 9. Functional status score by exam cycle according to vitamin D & 
weight-adjusted protein interaction intake among all subjects 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 10. Functional status score by exam cycle according to calcium & protein 
per kg intake among all subjects 
 
 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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Figure 11. Functional status score by exam cycle according to Vitamin D & 
protein per kg intake among all subjects 
 
 
 
Adjusted for sex, age, education, physical activity and cigarettes per day, height, and energy intake 
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